10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2023

OR

[_]  TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM _______________ TO _______________

COMMISSION FILE NUMBER: 000-55079

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

Nevada	27-2343603
(State or other jurisdiction of Incorporation or organization)	(I.R.S. Employer Identification Number)
10800 Galaxie Avenue Ferndale, MI	48220
(Address of principal executive offices)	(Zip code)

(877) 787-6268

(Registrant’s telephone number, including area code)

not applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:  None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X]   No [_]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X]   No [_]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	[_]	Accelerated filer	[_]
Non-accelerated filer	[X]	Smaller reporting company	[X]
		Emerging growth company	[_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [_]   No [X]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 7,160,712,056 shares of common stock were issued and outstanding as of September 26, 2023.

Table of Contents

		PAGE
PART I	FINANCIAL INFORMATION
ITEM 1.	Financial Statements	3
	Condensed Consolidated Balance Sheets as of August 31, 2023 and February 28, 2023 (Unaudited)	3
	Condensed Consolidated Statements of Operations for the Three Months and Six Months Ended August 31, 2023 and 2022 (Unaudited)	4
	Condensed Consolidated Statements of Stockholders’ Deficit for the Six Months Ended August 31, 2023 and 2022 (Unaudited)	5-6
	Condensed Consolidated Statements of Cash Flows for the Six Months Ended August 31, 2023 and 2022 (Unaudited)	7
	Notes to the Consolidated Financial Statements (Unaudited)	8-25
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	31
ITEM 4.	Controls and Procedures	31
PART II	OTHER INFORMATION
ITEM 1.	Legal Proceedings	32
ITEM 1A.	Risk Factors	32
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	32
ITEM 3.	Defaults Upon Senior Securities	32
ITEM 4.	Mine Safety Disclosures	32
ITEM 5.	Other Information	32
ITEM 6.	Exhibits	33
SIGNATURES		33

- 2 -

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	August 31, 2023			February 28, 2023*
ASSETS
Current assets:
Cash	$	1,512,112		$	939,759
Accounts receivable, net		260,671			265,024
Device parts inventory, net		1,689,930			1,637,899
Prepaid expenses and deposits		675,258			596,310
Total current assets		4,137,971			3,438,992
Operating lease asset		1,148,682			1,208,440
Revenue earning devices, net of accumulated depreciation of $1,044,294 and $779,839, respectively		1,756,228			1,235,219
Fixed assets, net of accumulated depreciation of $276,530 and $182,002, respectively		328,591			315,888
Trademarks		27,080			27,080
Investment at cost		50,000			50,000
Security deposit		21,239			21,239
Total assets	$	7,469,791		$	6,296,858
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable and accrued expenses	$	1,276,960		$	1,343,379
Advances payable- related party		1,594			1,594
Customer deposits		34,698			9,900
Current operating lease liability		239,669			248,670
Current portion of deferred variable payment obligation		667,634			542,177
Loan payable - related party		260,746			206,516
Incentive compensation plan payable		1,104,000			979,000
Current portion of loans payable, net of discount of $966,767 and $1,651,597		19,403,219			9,918,389
Vehicle loan - current portion		38,522			38,522
Current portion of accrued interest payable		5,726,894			2,761,446
Total current liabilities		28,753,936			16,049,593
Non-current operating lease liability		901,321			950,541
Loans payable, net of discount of $4,654,370 and $4,130,291, respectively		7,175,990			15,554,069
Deferred variable payment obligation		2,525,000			2,525,000
Accrued interest payable		2,061,093			3,060,656
Total liabilities		41,417,340			38,139,859
Commitments and Contingencies
Stockholders' deficit:
Preferred Stock, undesignated; 15,545,650 shares authorized; no shares issued and outstanding at August 31, 2023 and February 28, 2023, respectively		—			—
Series G Convertible Preferred Stock. $0.001 par value; 100,000 shares authorized, no shares issued and outstanding at August 31, 2023 and February 28, 2023, respectively		—			—
Series E Preferred Stock, $0.001 par value; 4,350,000 shares authorized; 3,350,000 and 3,350,000 shares issued and outstanding, respectively		3,350			3,350
Series F Convertible Preferred Stock, $1.00 par value; 4,350 shares authorized; 2,533 and 2,533 shares issued and outstanding, respectively		2,533			2,533
Common Stock, $0.00001 par value; 10,000,000,000 shares authorized 7,039,806,793 and 5,848,741,599 shares issued, issuable and outstanding, respectively		70,399			58,489
Additional paid-in capital		87,445,715			80,247,252
Preferred stock to be issued		99,086			99,086
Accumulated deficit		(121,568,632	)		(112,253,711	)
Total stockholders' deficit		(33,947,549	)		(31,843,001	)
Total liabilities and stockholders' deficit	$	7,469,791		$	6,296,858

* Derived from audited information

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

- 3 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended			Three Months Ended			Six Months Ended			Six Months Ended
	August 31, 2023			August 31, 2022			August 31, 2023			August 31, 2022
Revenues	$	386,363		$	267,484		$	771,571		$	652,641
Cost of Goods Sold		89,014			34,214			180,525			327,938
Gross Profit		297,349			233,270			591,046			324,703
Operating expenses:
Research and development (Note 10)		794,548			963,786			1,686,305			1,987,521
General and administrative		2,294,471			2,238,442			4,414,902			4,638,834
Depreciation and amortization		191,041			145,793			358,983			239,788
Operating lease cost and rent		62,541			63,681			125,083			133,648
Total operating expenses		3,342,601			3,411,702			6,585,273			6,999,791
Loss from operations		(3,045,252	)		(3,178,432	)		(5,994,227	)		(6,675,088	)
Other income (expense), net:
Change in fair value of derivative liabilities		—			3,595			—			3,595
Interest expense		(1,753,216	)		(1,002,020	)		(3,359,432	)		(2,177,050	)
Gain (loss) on settlement of debt		38,740			3,992			38,740			3,992
Total other expense net		(1,714,476	)		(994,433	)		(3,320,692	)		(2,169,463	)
Net loss	$	(4,759,728	)	$	(4,172,865	)	$	(9,314,919	)	$	(8,844,551	)
Net loss per share - basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Net loss per share - diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Weighted average common share outstanding - basic		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362
Weighted average common share outstanding - diluted		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

- 4 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

	Series E			Series F								Additional						Total
	Preferred Stock			Preferred Stock			Common Stock					Paid-In			Accumulated			Stockholders’
	Shares	Amount		Shares	Amount		Shares		Amount			Capital			Deficit			Deficit
Balance at February 28, 2022	3,350,000	$	3,350	2,532	$	101,618	4,735,210,360		$	47,353		$	73,015,576		$	(94,144,254	)	$	(20,976,357	)
Issuance of shares, net of $117,157 issuance costs	—		—	—		—	133,881,576			1,339			1,643,883			—			1,645,222
Rounding	—		—	—		—	—			—			(1	)		—			(1	)
Net income	—		—	—		—	—			—			—			(4,671,686	)		(4,671,686	)
Balance at May 31, 2022	3,350,000	$	3,350	2,532	$	101,618	4,869,091,936		$	48,692		$	74,659,458		$	(98,815,940	)	$	(24,002,822	)
Issuance of shares, net of $95,293 issuance costs	—		—	—		—	191,691,135			1,917			1,889,350			—			1,891,267
Cashless exercise of warrants	—		—	—		—	9,688,179			97			(97	)		—			—
Relative fair value of warrants issued with debt	—		—	—		—	—			—			404,374			—			404,374
Cancelled shares	—		—	—		—	(17,116,894	)		(171	)		171			—			—
Exchange of 955,000,000 warrants for debt	—		—	—		—	—			—			(2,960,500	)					(2,960,500	)
Shares as payment for services	—		—	—		—	10,000,000			100			118,400			—			118,500
Net income	—		—	—		—	—			—			—			(4,172,865	)		(4,172,865	)
Balance at August 31, 2022	3,350,000	$	3,350	2,532	$	101,618	5,063,354,356		$	50,635		$	74,111,156		$	(102,988,805	)	$	(28,722,046	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

- 5 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT

(Unaudited)

	Series E			Series F						Additional					Total
	Preferred Stock			Preferred Stock			Common Stock			Paid-In		Accumulated			Stockholders’
	Shares	Amount		Shares	Amount		Shares	Amount		Capital		Deficit			Deficit
Balance at February 28, 2023	3,350,000	$	3,350	2,533	$	101,619	5,848,741,599	$	58,489	$	80,247,252	$	(112,253,711	)	$	(31,843,001	)
Issuance of shares, net of $81,285 issuance costs	—		—	—		—	280,929,190		2,809		1,316,100		—			1,318,909
Relative fair value of Series F warrants issued with loans payable	—		—	—		—	—		—		947,447					947,447
Stock based compensation	—		—	—		—	—		—		52,721		—			52,721
Net income	—		—	—		—	—		—		—		(4,555,193	)		(4,555,193	)
Balance at May 31, 2022	3,350,000	$	3,350	2,533	$	101,619	6,129,670,789	$	61,298	$	82,563,520	$	(116,808,904	)	$	(34,079,117	)
Issuance of shares, net of $176,672 issuance costs	—		—	—		—	903,636,004		9,036		4,787,087		—			4,796,123
Shares as payment for services	—		—	—		—	6,500,000		65		44,395		—			44,460
Stock based compensation	—		—	—		—	—		—		50,713		—			50,713
Net income	—		—	—		—	—		—		—		(4,759,728	)		(4,759,728	)
Balance at August 31, 2023	3,350,000	$	3,350	2,533	$	101,619	7,039,806,793	$	70,399	$	87,445,715	$	(121,568,632	)	$	(33,947,549	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

- 6 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Six Months Ended August 31, 2023			Six Months Ended August 31, 2022
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss	$	(9,314,919	)	$	(8,844,551	)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		358,983			239,786
Bad debts expense		24,730			145,000
Inventory provision		—			70,000
Reduction of right of use asset		58,220			56,854
Accretion of lease liability		66,864			72,090
Stock based compensation		228,434			343,000
Change in fair value of derivative liabilities		—			(3,595	)
Amortization of debt discounts		1,258,198			671,594
(Gain) loss on settlement of debt		(38,740	)		(3,992	)
Increase in related party accrued payroll and interest		54,230			6,480
Changes in operating assets and liabilities:
Accounts receivable		(20,377	)		(158,183	)
Prepaid expenses		(77,410	)		(23,984	)
Device parts inventory		(941,261	)		(632,760	)
Accounts payable and accrued expenses		16,775			351,014
Customer deposits		24,798			(8,128	)
Operating lease liabilities		(125,083	)		(128,944	)
Current portion of deferred variable payment obligation for payments		125,457			106,120
Accrued interest payable		1,965,885			987,737
Net cash used in operating activities		(6,335,216	)		(6,754,462	)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of fixed assets		(3,463	)		(207,197	)
Net cash used in investing activities		(3,463	)		(207,197	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs		6,115,032			3,255,289
Proceeds from loans payable		1,050,000			500,000
Repayment of loans payable		(254,000	)		(1,697,953	)
Proceeds from convertible debt and warrants issued		—			619,250
Net cash provided by financing activities		6,911,032			2,676,586
Net change in cash		572,353			(4,285,073	)
Cash, beginning of period		939,759			4,648,146
Cash, end of period	$	1,512,112		$	363,073
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	$	9,892		$	405,117
Cash paid for income taxes	$	—		$	—
Noncash investing and financing activities:
Transfer from device parts inventory to revenue earning devices	$	889,230		$	452,526
Exchange of warrants for debt	$	—		$	3,000,000
Discount applied to face value of loans	$	150,000		$	39,500
Exercise of warrants	$	—		$	97
Series F warrants issued as part of debt	$	947,447		$	—
Shares issued for services	$	44,460		$	—
Cancellation of Series E preferred shares and common shares	$	—		$	171

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

- 7 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. GENERAL INFORMATION

Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer.  As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

2. GOING CONCERN

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

For the six months ended August 31, 2023, the Company had negative cash flow from operating activities of $6,335,216. As of August 31, 2023, the Company has an accumulated deficit of $121,568,632, and negative working capital of $24,615,965. Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.

Management has plans to address the Company’s financial situation as follows:

Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In March 2023, the Company entered into an equity financing agreement whereby an investor will purchase up to $12,500,000 of the Company’s common stock at a discount over a two-year period.   In March and April 2023 the Company reduced personnel that were working on far-future solutions as well as other department reductions. Combined with other cost cutting measures management estimates it reduced the monthly expense burn by $ 200,000 - $ 300,000 with little impact on short and medium term operations. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways : growing revenues ,equity proceeds and non-convertible debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. The Company this fiscal quarter through to September 26, 2023 has raised an additional $5.2 million net of issuance costs through the sale of its common shares.

- 8 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

3. ACCOUNTING POLICIES

Basis of Presentation and Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 14, 2023. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the six months ended August 31, 2023 are not necessarily indicative of the results that may be expected for the entire year.

Use of Estimates

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.

Concentrations

Loans payable

At August 31, 2023 there were $32,200,345 of loans payable, $27,890,506 or 87% of these loans to companies controlled by one individual. At February 28, 2023 there were $31,254,345 of loans payable $26,540,506 or 85% of these loans to companies controlled by the same individual.

Cash

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

Accounts Receivable

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $59,000 and $39,000 provided as of August 31, 2023 and February 28, 2023, respectively. For the three months ended August 31, 2023 , two customers account for 37% of total accounts receivable . For the three months ended August 31, 2022 , four customers account for 54% of total accounts receivable.

Device Parts Inventory

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development.  A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of August 31, 2023 and February 28, 2023 there was a valuation reserve of $195,000 and $195,000, respectively.

- 9 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Revenue Earning Devices

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

Fixed Assets

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

Computer equipment and software	2 or 3 years
Office equipment	4 years
Manufacturing equipment	7 years
Warehouse equipment	5 years
Tooling	2 years
Demo Devices	4 years
Vehicles	3 years
Leasehold improvements	5 years, the life of the lease

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

Research and Development

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At August 31, 2023 and February 28, 2023, the Company had no deferred development costs.

Contingencies

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

Sales of Future Revenues

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

- 10 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

● Does the agreement purport, in substance, to be a sale

● Does the Company have continuing involvement in the generation of cash flows due the investor

● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets

● Is the investors rate of return is implicitly limited by the terms of the agreement

● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return

● Does the investor have recourse relating to payments due

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

Revenue Recognition

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the six months ended August 31, 2023 , two customers accounted for 33% of total revenue (2022- 26%).

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements

Leases

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

- 11 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

Distinguishing Liabilities from Equity

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

Initial Measurement

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

Subsequent Measurement – Financial Instruments Classified as Liabilities

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

- 12 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 – Inputs that are unobservable for the asset or liability.

Measured on a Recurring Basis

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

			Fair Value Measurement Using
	Amount at Fair Value		Level 1		Level 2		Level 3
August 31, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	1,104,000	$	—	$	—	$	1,104,000
February 28, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	979,000	$	—	$	—	$	979,000

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

Earnings (Loss) per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

- 13 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Recently Issued Accounting Pronouncements

Recently Issued Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. Adoption of the standard requires using either a modified retrospective or a full retrospective approach. Management is currently evaluating the effect of these provisions on the Company’s financial position and results of operations.

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

The following table presents revenues from contracts with customers disaggregated by product/service:

	Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	August 31, 2023		August 31, 2022		August 31, 2023		August 31, 2022
Device rental activities	$	343,543	$	228,214	$	581,692	$	468,019
Direct sales of goods and services		42,820		39,270		189,879		184,622
	$	386,363	$	267,484	$	771,571		652,641

- 14 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

5. LEASES

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

Below is a summary of our lease assets and liabilities at August 31, 2023 and February 28, 2023.

Leases	Classification	August 31, 2023		February 28, 2023
Assets
Operating	Operating Lease Assets	$	1,148,682	$	1,208,440
Liabilities
Current
Operating	Current Operating Lease Liability	$	239,669	$	248,670
Noncurrent
Operating	Noncurrent Operating Lease Liabilities		901,321		950,541
Total lease liabilities		$	1,140,990	$	1,199,211

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

Rent expense and operating lease cost was $62,541 and $125,083 for the three and six months ended August 31, 2023, respectively, and $63,681 and $133,648 for the three and six months ended August 31, 2022, respectively.

6. REVENUE EARNING DEVICES

Revenue earning devices consisted of the following:

	August 31, 2023			February 28, 2023
Revenue earning devices	$	2,800,522		$	2,015,058
Less: Accumulated depreciation		(1,044,294	)		(779,839	)
	$	1,756,228		$	1,235,219

During the three and six months ended August 31, 2023 the Company made total additions to revenue earning devices of $341,042 and $785,464, respectively, which were transfers from inventory. During the three and six months ended August 31, 2022 the Company made total additions to revenue earning devices of $251,946 and $426,047, respectively, which were transfers from inventory.

Depreciation expense was $141,614 and $264,455 for the three and six months ended August 31, 2023, respectively, and $116,125 and $187,539 for the three and six months ended August 31, 2022, respectively.

- 15 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

7. FIXED ASSETS

Fixed assets consisted of the following:

	August 31, 2023			February 28, 2023
Automobile	$	101,680		$	101,680
Demo devices		172,778			69,010
Tooling		101,322			101,322
Machinery and equipment		8,825			8,825
Computer equipment		150,387			150,387
Office equipment		15,312			15,312
Furniture and fixtures		21,225			21,225
Warehouse equipment		14,561			14,561
Leasehold improvements		19,031			15,568
		605,121			497,890
Less: Accumulated depreciation		(276,530	)		(182,002	)
	$	328,591		$	315,888

During the three months ended August 31, 2023, the Company made additions of $75,057 which were transfers from inventory. During the six months ended August 31, 2023, the Company made additions of $107,230 of which $103,767 were transfers from inventory with remaining additions of $3,463. During the three months ended August 31, 2022, the Company made additions of $139,946 of which $20,693 were transfers from inventory with remaining additions of $118,983. During the six months ended August 31, 2022, the Company made additions of $233,676 of which $26,479 were transfers from inventory with remaining additions of $207,197.

Depreciation expense was $49,427 and $94,528 for the three and six months ended August 31, 2023, respectively, and $29,668 and $52,249 for the three and six months ended August 31, 2022, respectively.

8. DEFERRED VARIABLE PAYMENT OBLIGATION

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

On May 9, 2019 the Company entered into two similar arrangements with two investors:

(1)	The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
(2)	The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

- 16 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of August 31, 2023, the Company has accrued $667,634 in Payments of which $431,719 are in arrears. As of February 28, 2023, the Company has accrued $542,177 in Payments of which $325,600 are in arrears. No notices have been sent to the Company.

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

1)	The rate payment was reduced from 14.25 % to 9.65 %
2)	The asset disposition % (see below) was reduced from 31 % to 21%

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

- 17 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of August 31, 2023, and February 28, 2023, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

For both the three months and six months ended August 31, 2023 and year ended February 28, 2023, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both August 31, 2023 and February 28, 2023.

9. RELATED PARTY TRANSACTIONS

For both the three months ended August 31, 2023 and August 31, 2022 , the Company had no repayments of net advances from its loan payable-related party At August 31, 2023, the loan payable-related party was $260,746 and $206,516 at February 28, 2023. Included in the balance due to the related party at August 31, 2023 is $172,265 of deferred salary and interest, $145,500 of which bears interest at 12%. At February 28, 2023, included in the balance due to the related party is $108,000 of deferred salary with $108,000 bearing interest at 12%. The accrued interest included in loan at August 31, 2023 and February 28, 2023 was $23,515 and $15,660 respectively.

Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended August 31, 2023, the Company accrued $62,000 (2022-$63,000) and $125,000 (2022-$224,500) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At August 31, 2023 and February 28, 2023 there was $1,104,000 and $979,000 of incentive compensation payable.

During the three months ended August 31, 2023 and 2022, the Company was charged $777,260 and $957,395, respectively for fees for research and development from a company partially owned by a principal shareholder.

During the six months ended August 31, 2023 and 2022, the Company was charged $1,659,275 and $1,959,129, respectively for fees for research and development from a company partially owned by a principal shareholder.

10. OTHER DEBT – VEHICLE LOAN

In December 2016, RAD entered into a vehicle loan for $47,704 secured by the vehicle. The loan is repayable over 5 years maturing November 9, 2021, and repayable $1,019 per month including interest and principal. In November 2017, RAD entered into another vehicle loan secured by the vehicle for $47,661. The loan is repayable over 5 years, maturing October 24, 2022 and repayable at $923 per month including interest and principal. The principal repayments made were $0 for both the year ended February 28, 2022 and February 28, 2021. Regarding the second vehicle loan, the vehicle was returned at the end of fiscal 2019 and the car was subsequently sold by the lender for proceeds of $21,907 which went to reduce the outstanding balance of the loan. A loss of $3,257 was recorded as well. A balance of $21,578 remains on this vehicle loan at both February 28, 2021 and February 29, 2020. For the first vehicle loan, the vehicle was retired in 2020, the proceeds of the disposal of $18,766 was applied against the balance of the loan with a $5,515 gain on the remaining asset value of $13,251. A balance of $16,944 remains on this vehicle loan at both February 28, 2022 and February 28, 2021. The remaining total balances of the amounts owed on the vehicle loans were $38,522 and $38,522 as of August 31, 2023 and February 28, 2023, respectively, of which all were classified as current.

- 18 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

11. LOANS PAYABLE

Loans payable at August 31, 2023 consisted of the following:

							Annual
Date	Maturity	Description		Principal			Interest Rate
July 18, 2016	July 18, 2017	Promissory note	(1) *	$	3,500		22%
December 10, 2020	December 10, 2023	Promissory note	(2)		3,921,168		12%
December 10, 2020	December 10, 2023	Promissory note	(3)		3,054,338		12%
December 10, 2020	December 10, 2023	Promissory note	(4)		165,605		12%
December 14, 2020	December 14, 2023	Promissory note	(5)		310,375		12%
December 30, 2020	December 30, 2023	Promissory note	(6)		350,000		12%
January 1, 2021	January 1, 2024	Promissory note	(7)		25,000		12%
January 1, 2021	January 1, 2024	Promissory note	(8)		145,000		12%
January 14, 2021	January 14, 2024	Promissory note	(9)		550,000		12%
February 22, 2021	February 22, 2024	Promissory note	(10)		1,650,000		12%
March 1, 2021	March 1, 2024	Promissory note	(11)		6,000,000		12%
June 8, 2021	June 8, 2024	Promissory note	(12)		2,750,000		12%
July 12, 2021	July 26, 2026	Promissory note	(13)		3,830,360		7%
September 14, 2021	September 14, 2024	Promissory note	(14)		1,650,000		12%
July 28, 2022	July 28, 2023	Promissory note	(15)		—		15%
August 30, 2022	August 30,2024	Promissory note	(16)		3,000,000		15%
September 7, 2022	September 7, 2023	Promissory note	(17)		370,000		15%
September 8, 2022	September 8, 2023	Promissory note	(18)		475,000		15%
October 13, 2022	October 13, 2023	Promissory note	(19)		350,000		15%
October 28, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 9, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 10, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 15, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
January 11, 2023	October 31,2026	Promissory note	(20)		400,000		15%
February 6, 2023	October 31, 2026	Promissory note	(20)		400,000		15%
April 5. 2023	October 31, 2026	Promissory note	(20)		400,000		15%
April 20, 23	October 31, 2026	Promissory note	(20)		400,000		15%
May 11, 2023	October 31, 2026	Promissory note	(20)		400,000		15%
				$	32,200,346
Less: current portion of loans payable					(20,369,986	)
Less: discount on non-current loans payable					(4,654,370	)
Non-current loans payable, net of discount				$	7,175,990
Current portion of loans payable				$	20,369,986
Less: discount on current portion of loans payable					(966,767	)
Current portion of loans payable, net of discount				$	19,403,219

* In default

- 19 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(1)	This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
(2)	This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(3)	This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(4)	This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.
(5)	This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.
(6)	The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $52,756 and $92,660, respectively, with an unamortized discount of $100,855 at August 31, 2023.
(7)	This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(8)	This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(9)	The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $62,143 and $113,188 respectively, with an unamortized discount of $126,148 at August 31, 2023.
(10)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $220,757 and $379,821 respectively, with an unamortized discount of $732,440 at August 31, 2023.

- 20 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(11)	The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized.
(12)	The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $175,789 and $330,699 respectively, with an unamortized discount of $463,519 at August 31, 2023.
(13)	This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2023 there were repayments of  $27,000 and $54,000 . respectively on the note.
(14)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $115,344 and $202,274 respectively, with an unamortized discount of $1,27,501 at August 31, 2023.
(15)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $3,739 and $9,026 respectively, with an unamortized discount of $0 at August 31, 2023. This loan has been fully repaid.
(16)	A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $4,736 and $9,293 respectively, with an unamortized discount of $21,576 at August 31, 2023.
(17)	Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000.  Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $15,479 and $27,821 respectively, with an unamortized discount of $0 at August 31, 2023.
(18)	Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $17,799 and $36,729 respectively, with an unamortized discount of $0 at August 31, 2023.
(19)	Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $13,295 and $25,585 respectively, with an unamortized discount of $7,325 at August 31, 2023.

- 21 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At November 30, 2022 the Company has issued 6 tranches as follows:

October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,472 and $4,338 respectively, with an unamortized discount of $343,685 at August 31, 2023.

November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,438 and $4,276 respectively, with an unamortized discount of $344,162 at August 31, 2023.

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,233 and $3,900 respectively, with an unamortized discount of $346,981 at August 31, 2023.

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,489 and $4,370 respectively, with an unamortized discount of $343,445 at August 31, 2023.

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,541 and $4,565 respectively, with an unamortized discount of $342,724 at August 31, 2023.

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,436 and $4,272 respectively, with an unamortized discount of $344,154 at August 31, 2023.

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,523 and $3,274 respectively, with an unamortized discount of $342,971 at August 31, 2023.

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,010 and $2,206 respectively, with an unamortized discount of $350,013 at August 31, 2023.

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $0 and $0 respectively, with an unamortized discount of $398,983 at August 31, 2023.

- 22 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

13. STOCKHOLDERS’ EQUITY (DEFICIT)

Summary or Preferred Stock Activity

No preferred stock activity during the period.

Summary of Preferred Stock Warrant Activity

	Number of Series F Preferred Warrants	Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at March 1, 2023	695	$1.00	10.00
Issued	183	1.00	9.88
Exercised	—	—	—
Forfeited and cancelled	—	—	—
Outstanding at August 31, 2023	878	$1.00	9.75

During the six months ended August 31, 2023, as part of debt issuance the Company issued 183 Series F Preferred Warrants to a lender for a relative fair value of $947,447. (see Note 11)

Summary of Common Stock Activity

The Company increased authorized common shares from 7,225,000,000 to 10,000,000,000 on August 30, 2023.

For the three months ended August 31, 2023, the Company issued 903,636,004 common shares with gross proceeds of $4,972,795 and net proceeds of $4,796,193 after issuance costs of $176,672. For the six months ended August 31, 2023, the Company issued 1,184,565,194 common shares with gross proceeds of $6,372,989 and net proceeds of $6,115,032 after issuance costs of $257,956. In addition for the three and six months ended the Company issued 6,500,000 shares with a fair value of $ 44,460 as payment for services of $ 83,200. A gain on settlement of debt of $38,640 has been recorded. The Company also issued 12,100,000 previously recorded as issuable shares pursuant to agreements.

The table below represent the common shares issued, issuable and outstanding at August 31, 2023 and February 28, 2023:

Common shares	August 31, 2023		February 28, 2023
Issued		7,039,806,793		5,836,641,599
Issuable		—		12,100,000
Issued, issuable and outstanding		7,039,806,793		5,848,741,599

Summary of Common Stock Warrant Activity

For the three months and six months ended August 31, 2023 and August 31, 2022, the Company recorded a total of $50,713 and $0, and $103,434 and $0 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

	Number of Warrants	Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at February 28, 2023	314,217,451	$0.114	1.95
Issued	—	—	—
Exercised	—	—	—
Forfeited and cancelled	—	—	—
Outstanding at August 31, 2023	314,217,451	$0.114	1.45

- 23 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Summary of Common Stock Option Activity -Employee Stock Options

	Number of Options		Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at February 28 , 2023	95,725,000		$0.02	4.75
Issued	—		—	—
Exercised	—		—	—
Forfeited, extinguished and cancelled	(13,025,000	)	$0.02	(4.75)
Outstanding at August 31, 2023	82,700,000		$0.02	4.25

15. COMMITMENTS AND CONTINGENCIES

Litigation

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

The related legal costs are expensed as incurred.

Operating Lease

On December 18, 2020, the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E, Irvine CA, 92614, commencing on December 18, 2020 through to March 31, 2022 with a minimum base rent of $3,859 per month. The Company paid a security deposit of $3,859.

On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.

On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month. The Company paid a security deposit of $1,500.

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $62,541 and $125,083 for the three and six months ended August 31, 2023, respectively, and $63,681 and $133,648 for the three and six months ended August 31, 2022, respectively.

Maturity of Lease Liabilities	Operating Leases
August 31, 2024	$	239,669
August 31, 2025		207,558
August 31, 2026		207,558
August 31, 2027		207,558
August 31, 2028		207,558
August 31, 2029 and after		553,488
Total lease payments		1,623,389
Less: Interest		(482,399	)
Present value of lease liabilities	$	1,140,990

- 24 -

ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

16. EARNINGS (LOSS) PER SHARE

The net income (loss) per common share amounts were determined as follows:

	For the Three Months Ended						For the Six Months Ended
	August 31,						August 31,
	2023			2022			2023			2022
Numerator:
Net income (loss) available to common shareholders	$	(4,759,728	)	$	(4,172,865	)	$	(9,314,919	)	$	(8,844,551	)
Effect of common stock equivalents
Add: interest expense on convertible debt		—			8,543			—			8,737
Add (less) loss (gain) on settlement of debt		—			(3,992	)		—			(3,992	)
Add (less) loss (gain) on change of derivative liabilities		—			(3,595	)		—			(3,595	)
Net income (loss) adjusted for common stock equivalents		(4,759,728	)		(4,171,909	)		(9,314,919	)		(8,843,401	)
Denominator:
Weighted average shares – basic		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362
Net income (loss) per share – basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)
Dilutive effect of common stock equivalents:
Convertible Debt		—			—			—			—
Preferred shares		—			—			—			—
Warrants		—			—			—			—
		—			—			—			—
Denominator:
Weighted average shares – diluted		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362
Net income (loss) per share – diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)

The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2023 and 2022 were as follows:

	For the Three Months Ended				For the Six Months Ended
	August 31,				August 31,
	2023		2022		2023		2022
Convertible notes and accrued interest		—		836,425,685		—		836,425,685
Convertible Series F Preferred Shares		24,286,988,436		—		24,286,988,436		—
Stock options and warrants		433,767,451		401,217,451		433,767,451		401,217,451
Total		24,720,755,887		1,237,643,136		24,720,755,887		1,237,643,136

* On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at August 31, 2023 and 2022 the dilutive effects would be as follows:

	For the Three and Six Months Ended
	August 31, 2023	August 31, 2022
Convertible Series F Preferred Shares	—	17,375,422,528

17. SUBSEQUENT EVENTS

Subsequent to August 31, 2023 through to October 12, 2023:

—   The Company issued 120,905,263 common shares pursuant to a share purchase agreement for gross proceeds of $377,224, issuance costs of $8,569 and net proceeds of $368,655.

- 25 -

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The following discussion of our financial condition and results of operations for the three and six months ended August 31, 2023 and August 31, 2022 should be read in conjunction with our unaudited consolidated financial statements and the notes to those statements that are included elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under Item 1A. Risk Factors appearing in our Annual Report on Form 10-K for the year ended February 28, 2023, as filed on June 14, 2023 with the SEC. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

Unless expressly indicated or the context requires otherwise, the terms “AITX”, the “Company”, “we”, “us”, and “our” refer to Artificial Intelligence Technology Solutions Inc.

Overview

AITX was incorporated in Florida on March 25, 2010. AITX reincorporated into Nevada on February 17, 2015. AITX’s fiscal year end is February 28 (February 29 during leap year). AITX is located at 10800 Galaxie Ave., Ferndale Michigan, 48220, and our telephone number is 877-767-6268.

AITX’s mission is to apply Artificial Intelligence (AI) technology to solve enterprise problems categorized as expensive, repetitive, difficult to staff, and outside of the core competencies of the client organization.

A short list of basic examples include:

1.	Typical security guard-related functions such as monitoring a parking lot during and after hours and responding appropriately. This scenario applies to perimeters, interior yard areas, and related similar environments.
2.	Integrated hardware/software with AI-driven responses, simulating and expanding on what legacy or manned solutions could perform.
3.	Automation of common access control functions through technology utilizing facial recognition and machine vision, leapfrogging most legacy solutions in use today.

RAD solutions are unique because they:

1.	Start with an AI-driven autonomous response utilizing cellular-optimized communications, while easily connecting to a human operator for a manned response, as needed.
2.	Use unique hardware purpose-built by RAD for delivery of these solutions. Various form factors have been customized to deliver this new functionality.
3.	Deliver services through RAD-developed software and cloud services, allowing enterprise IT groups to focus on core competencies instead of maintenance of complex video and security platforms.

We encourage everyone to ensure they have the most up to date news by visiting AITX at AITX News - AITX - Artificial Intelligence Technology Solutions.

- 26 -

Management Discussion and Analysis

Results of Operations for the Three Months Ended August 31, 2023 and 2022

The following table shows our results of operations for the three months ended August31, 2022 and 2021. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

	Period
	Three Months Ended			Three Months Ended			Change
	August 31, 2023			August 31, 2022			Dollars			Percentage
Revenues	$	386,363		$	267,484		$	118,879		44%
Gross profit		297,349			233,270			64,079		27%
Operating expenses		3,342,601			3,411,702			(69,101	)	(2%	)
Loss from operations		(3,045,252	)		(3,178,432	)		133,180		(4%	)
Other income (expense), net		(1,714,476	)		(994,433	)		(720,043	)	72%
Net Loss	$	(4,759,728	)	$	(4,172,865	)	$	(586,863	)	14%

Revenue

The following table presents revenues from contracts with customers disaggregated by product/service:

	Three Months Ended		Three Months Ended		Change
	August 31, 2023		August 31, 2022		Dollars		Percentage
Device rental activities	$	343,543	$	228,214	$	115,329	51%
Direct sales of goods and services		42,820		39,270		3,550	9%
	$	386,363	$	267,484	$	118,879	44%

Total revenue for the three-month period ended August 31, 2023 was $386,363 which represented an increase of $118,879 compared to total revenue of $267,484 for the three months ended August 31, 2022. This increase is a result of higher rental sales in the current year’s quarter. Rental activities increased by 51% over the prior year’s quarter as the Company continues to grow its core business.

Gross profit

Total gross profit for the three-month period ended August 31, 2023 was $297,349, which represented an increase of $64,079 compared to gross profit of $233,270 for the three months ended August 31, 2022. The gross profit increased due to the higher sales.. The gross profit % of 77% for the three-month period ended August 31, 2023 was lower than the gross profit % of 87% for the prior year’s corresponding period.

Operating Expenses

	Period
	Three Months Ended		Three Months Ended		Change
	August 31, 2023		August 31, 2022		Dollars			Percentage
Research and development	$	794,548	$	963,786	$	(169,238	)	(18%	)
General and administrative		2,294,471		2,238,442		56,029		3%
Depreciation and amortization		191,041		145,793		45,248		31%
Operating lease cost and rent		62,541		63,681		(1,140	)	(2%	)
Operating expenses	$	3,342,601	$	3,411,702	$	(69,101	)	(2%	)

- 27 -

Our operating expenses were comprised of general and administrative expenses, research and development, and depreciation. General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the three-month period ended August 31, 2023 and August 31, 2022, were $3,342,601 and $3,411,702, respectively. The overall decrease of $69,101 was primarily attributable to the following changes in operating expenses of:

● General and administrative expenses increased by $56,029. In comparing the three months ended August 31, 2023 and August 31, 2022 the decrease in G&A was primarily due to decreases in wages and salaries of $130,629 due to reduction in force, stock-based compensation of $68,727, office expenses of $12,885, travel $43,876, and bad debts expense of $31,270 due to fewer slow payers. These decreases were partially offset by an increase in professional fees of $173,170 mostly due compliance and audit fees increase and other G&A increases.

● Research and development decreased by $169,238 due to a reduction in funding on development of future products.

● Depreciation and amortization increased by $45,248 due to large increases in revenue earning devices, demo devices, tooling and computer equipment.

● Operating lease cost and rent decreased by $1,140.

Other Income (Expense)

Other income (expense) consisted of interest. Other income (expense) during the three months ended August 31, 2023 and August 31, 2022, was ($1,714,476) and ($994,433), respectively. The $720,043 increase in other expense was primarily attributable to the increase in interest and amortization of debt due to higher loans.

Net loss

We had a net loss of $4,759,728 for the three months ended August 31, 2023, compared to a net loss of $4,172,865 for the three months ended August 31, 2022. The increase in net loss of $586,863 is primarily a result of higher other expenses consisting of interest and debt amortization costs. This increase was partially offset by higher gross profit and lower operating expenses.

Results of Operations for the Six Months Ended August 31, 2023 and 2022

The following table shows our results of operations for the six months ended August 31, 2023 and 2022. The historical results presented below are not necessarily indicative of the results that may be expected for any future period.

Revenue

	Period
	Six Months Ended			Six Months Ended			Change
	August 31, 2023			August 31, 2022			Dollars			Percentage
Revenues	$	771,571		$	652,641		$	118,930		18%
Gross profit		591,046			324,703			266,343		82%
Operating expenses		6,585,273			6,999,791			(414,518	)	(6%	)
Loss from operations		(5,994,227	)		(6,675,088	)		680,681		(10%	)
Other income (expense), net		(3,320,692	)		(2,169,463	)		(1,151,229	)	53%
Net loss	$	(9,314,919	)	$	(8,844,551	)	$	(470,368	)	5%

The following table presents revenues from contracts with customers disaggregated by product/service:

	Six Months Ended		Six Months Ended		Change
	August 31, 2023		August 31, 2022		Dollars		Percentage
Device rental activities	$	581,692	$	468,019	$	113,673	24%
Direct sales of goods and services		189,879		184,622		5,257	3%
	$	771,571	$	652,641	$	118,930	18%

- 28 -

Total revenue for the six-month period ended August 31, 2023 was $771,571 which represented an increase of $118,930 compared to total revenue of $652,641 for the six months ended August 31, 2022. This increase is a result of higher rental sales as the Company deployed 81more units when comparing these periods.

Gross profit

Total gross profit for the six-month period ended August 31, 2023 was $591,046 which represented an increase of $266,343, compared to gross profit of $324,703 for the six months ended August 31, 2022. The gross profit increased due to the higher sales and higher margin sales. The gross profit % of 77% for the six month period ended August 31, 2023 was higher than the gross profit % of 50% for the prior year’s corresponding period. The direct sales for the six months ended August 31, 2023 consisted of higher proportion of training revenue at higher gross profit vs unit sales for the six months ended August 31, 2022. The gross profit % of 77% for the six month period ended August 31, 2023 was higher than the gross profit % of 50% for the prior year’s corresponding period.

Operating Expenses

	Period
	Six Months Ended		Six Months Ended		Change
	August 31, 2023		August 31, 2022		Dollars			Percentage
Research and development	$	1,686,305	$	1,987,521	$	(301,216	)	(15%	)
General and administrative		4,414,902		4,638,834		(223,932	)	(5%	)
Depreciation and amortization		358,983		239,788		119,195		50%
Operating lease cost and rent		125,083		133,648		(8,565	)	(6%	)
Operating expenses	$	6,585,273	$	6,999,791	$	(414,518	)	(6%	)

General and administrative expenses consisted primarily of professional services, automobile expenses, advertising, salaries and wages, travel expenses and consultants. Our operating expenses during the six-month period ended August 31, 2023 and August 31, 2022, were $6,585,273 and $6,999,791, respectively. The overall decrease of $414,518 was primarily attributable to the following changes in operating expenses of:

● General and administrative expenses decreased by $223,932. In comparing the six months ended August 31, 2023 and August 31, 2022 the decrease may be partially explained by the following decreases: wages and salaries by $181,156, stock based compensation by $114,506, subcontractors by $26,541, sales and marketing by $49,346, travel by $39,971, investor relations stock agents and regulatory expenses by $35,772, bad debts expense $120,270 and office expense by $19,972. These were partially offset by increases in the following account: professional fees by $259,677 and other G& A increases.

● Research and development decreased by $301,216 due to a reduction in funding on development of future products.

● Depreciation and amortization increased by $119,195 due to the acquisition of ERP computer software, computer equipment tooling, and 81 new revenue earning devices.

● Operating lease cost and rent decreased by $8,565 due to one less lease in the current period.

Other Income (Expense)

Other income (expense) during the six months ended August 31, 2023 and August 31, 2022, was ($3,320,692) and ($2,169,463), respectively. The $1,151,229 increase in other expense was primarily attributable to the increase in interest and debt amortization expense which is a result of higher loans in 2023.

Net loss

We had a net loss of 9,314,919 for the six months ended August 31, 2023, compared to a net loss of $8,844,551 for the six months ended August 31, 2022. The increase in net loss of $470,368 is primarily a result of higher other expenses consisting of interest and debt amortization costs. This increase was partially offset by higher gross profit and lower operating expenses

- 29 -

Liquidity, Capital Resources and Cash Flows

Management believes that we will continue to incur losses for the immediate future. Therefore, we will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities, if ever. These conditions raise substantial doubt about our ability to continue as a going concern. Our unaudited condensed consolidated financial statements do not include and adjustments relating to the recovery of assets or the classification of liabilities that may be necessary should we be unable to continue as a going concern.

As of August 31, 2023, we had a cash balance of $1,512,112, accounts receivable of $260,671, device parts inventory of $1,689,930 and $28,753,936 in current liabilities. At the current cash consumption rate, we will need to consider additional funding sources going forward. We are taking proactive measures to reduce operating expenses and drive growth in revenue.

The successful outcome of future activities cannot be determined at this time and there is no assurance that, if achieved, we will have sufficient funds to execute our intended business plan or generate positive operating results.

Capital Resources

The following table summarizes total current assets, liabilities and working capital (deficit) for the periods indicated:

	August 31, 2023			February 28, 2023
Current assets	$	4,137,971		$	3,438,992
Current liabilities		28,753,936			16,049,593
Working capital	$	(24,615,965	)	$	(12,610,601	)

As of August 31, 2023 and February 28, 2023, we had a cash balance of $1,512,112 and $939,759, respectively.

Summary of Cash Flows

Summary of Cash Flows	Six Months Ended August 31, 2023			Six Months Ended August 31, 2022
Net cash used in operating activities	$	(6,335,216	)	$	(6,754,462	)
Net cash used in investing activities	$	(3,463	)	$	(207,197	)
Net cash provided by financing activities	$	6,911,032		$	2,676,586

Net cash used in operating activities.

Net cash used in operating activities for the six months ended August 31, 2023 was $6,335,216 which included a net loss of $9,314,919, non-cash activity such as the bad debts expense of $24,730, reduction of right of use asset of $58,220, accretion of lease liability $66,864, stock based compensation of $228,434, gain on settlement of debt of ($38,740) , change in operating assets and liabilities of $968,783, amortization of debt discount of $1,258,198, increase in related party accrued payroll and interest of $54,230 and depreciation and amortization of $358,983 to derive the uses of cash in operations.

Net cash used in investing activities.

Net cash used in investing activities for the six months ended August 31, 2023 was $3,463, which was the purchase of fixed assets,

Net cash provided by financing activities.

Net cash provided by financing activities was $6,911,032 for the six months ended August 31, 2023. This consisted of share proceeds net of issuance costs of 6,115,032, proceeds from loans payable of $1,050,000, reduced by repayments on loans payable of $254,000.

Off-Balance Sheet Arrangements

None.

- 30 -

Critical Accounting Policies and Estimates

Critical accounting policies and estimates are further discussed in our Annual Report on Form 10-K for the year ended February 28, 2023, as filed on June 14, 2023.

Related Party Transactions

For both the three months ended August 31, 2023 and August 31, 2022 , the Company had no repayments of net advances from its loan payable-related party. At August 31, 2023, the loan payable-related party was $260,746 and $206,516 at February 28, 2023. Included in the balance due to the related party at August 31, 2023 is $172,265 of deferred salary and interest, $145,500 of which bears interest at 12%. At February 28, 2023, included in the balance due to the related party is $108,000 of deferred salary with $108,000 bearing interest at 12%. The accrued interest included in loan at August 31, 2023 and February 28, 2023 was $23,515 and $15,660 respectively.

Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended August 31, 2023, the Company accrued $62,000 (2022-$63,000) and $125,000 (2022-$224,500) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At August 31, 2023 and February 28, 2023 there was $1,104,000 and $979,000 of incentive compensation payable.

During the three months ended August 31, 2023 and 2022, the Company was charged $777,260 and $957,395, respectively for fees for research and development from a company partially owned by a principal shareholder.

During the six months ended August 31, 2023 and 2022, the Company was charged $1,659,275 and $1,959,129, respectively for fees for research and development from a company partially owned by a principal shareholder.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable for a smaller reporting company.

ITEM 4. CONTROLS AND PROCEDURES

Management’s Report on Internal Control over Financial Reporting

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of August 31, 2023. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of August 31, 2023, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed by us under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

1.

As of August 31, 2023, we did not maintain effective controls over our control environment. Specifically, we have not developed and effectively communicated to our employees our accounting policies and procedures. This has resulted in inconsistent practices. Further, the Board of Directors does not currently have any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K. Since these entity level programs have a pervasive effect across the organization, management has determined that these circumstances constitute a material weakness.

2.

As of August 31, 2023, we did not maintain effective controls over financial statement disclosure. Specifically, controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements. Accordingly, management has determined that this control deficiency constitutes a material weakness.

Our management, including our principal executive officer and principal financial officer, do not expect that our disclosure controls and procedures or our internal controls will prevent all error or fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

- 31 -

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

This item is not applicable to smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Each issuance of securities was issued without registration in reliance of the exemption from registration Section 3(a)9 of the Securities Act of 1933.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

The Company has not defaulted upon senior securities.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable to the Company.

ITEM 5. OTHER INFORMATION

None.

- 32 -

ITEM 6. EXHIBITS

Exhibit No.	Description of Document
3.1	Articles of Incorporation (1)
3.2	Bylaws (2)
14	Code of Ethics (2)
21	Subsidiaries of the Registrant (3)
31.1	Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer. (3)
31.2	Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial and accounting officer. (3)
32.1	Section 1350 Certification of principal executive officer. (3)
32.2	Section 1350 Certification of principal financial accounting officer. (3)
101.INS	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. (3)
101.SCH	Inline XBRL Taxonomy Extension Schema Document (3)
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document (3)
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document (3)
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document (3)
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document (3)
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) (3)

__________

(1)	Incorporated by reference to our Form 10-KT file with the Securities and Exchange Commission on March 12, 2018.
(2)	Incorporated by reference to our Form S-1 filed with the Securities and Exchange Commission on August 4, 2010.
(3)	Filed or furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Artificial Intelligence Technology Solutions Inc.
Date: October 12, 2023	BY: /s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)
Date: October 12, 2023	BY: /s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

- 33 -

EX-21

Exhibit 21.1

Artificial Intelligence Technology Solutions Inc.

Subsidiaries

Name	Jurisdiction of Incorporation
Robotic Assistance Devices, Inc.	Nevada
Robotic Assistance Devices Group, Inc.	Nevada
Robotic Assistance Devices Mobile, Inc.	Nevada

EX-31

Exhibit 31.1

RULE 13A-14(A)/15D-14(A) CERTIFICATION

I, Steven Reinharz, certify that:

1. I have reviewed this Form 10-Q for the period ended August 31, 2023 of Artificial Intelligence Technology Solutions Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 12, 2023	BY: /s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)

EX-31

Exhibit 31.2

RULE 13A-14(A)/15D-14(A) CERTIFICATION

I, Anthony Brenz, certify that:

1. I have reviewed this Form 10-Q for the period ended August 31, 2023 of Artificial Intelligence Technology Solutions Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15-d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 12, 2023	BY: /s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

EX-32

Exhibit 32.1

SECTION 1350 CERTIFICATION

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the “Company”) on Form 10-Q for the period ended August 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, Steven Reinharz, President of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: October 12, 2023	BY: /s/ Steven Reinharz
	Steven Reinharz
	President, Chief Executive Officer (principal executive officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32

Exhibit 32.2

SECTION 1350 CERTIFICATION

In connection with the quarterly report of Artificial Intelligence Technology Solutions Inc. (the “Company”) on Form 10-Q for the period ended August 31, 2023 as filed with the Securities and Exchange Commission (the “Report”), I, Anthony Brenz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: October 12, 2023	BY: /s/ Anthony Brenz
	Anthony Brenz
	Chief Financial Officer (principal financial officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	6 Months Ended
	Aug. 31, 2023	Sep. 26, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Aug. 31, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--02-28
Entity File Number	000-55079
Entity Registrant Name	ARTIFICIAL INTELLIGENCE TECHNOLOGY SOLUTIONS INC.
Entity Central Index Key	0001498148
Entity Tax Identification Number	27-2343603
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	10800 Galaxie Avenue
Entity Address, City or Town	Ferndale
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48220
City Area Code	877
Local Phone Number	787-6268
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		7,160,712,056

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Current assets:
Cash	$ 1,512,112	$ 939,759	[1]
Accounts receivable, net	260,671	265,024	[1]
Device parts inventory, net	1,689,930	1,637,899	[1]
Prepaid expenses and deposits	675,258	596,310	[1]
Total current assets	4,137,971	3,438,992	[1]
Operating lease asset	1,148,682	1,208,440	[1]
Revenue earning devices, net of accumulated depreciation of $1,044,294 and $779,839, respectively	1,756,228	1,235,219	[1]
Fixed assets, net of accumulated depreciation of $276,530 and $182,002, respectively	328,591	315,888	[1]
Trademarks	27,080	27,080	[1]
Investment at cost	50,000	50,000	[1]
Security deposit	21,239	21,239	[1]
Total assets	7,469,791	6,296,858	[1]
Current liabilities:
Accounts payable and accrued expenses	1,276,960	1,343,379	[1]
Advances payable- related party	1,594	1,594	[1]
Customer deposits	34,698	9,900	[1]
Current operating lease liability	239,669	248,670	[1]
Current portion of deferred variable payment obligation	667,634	542,177	[1]
Loan payable - related party	260,746	206,516	[1]
Incentive compensation plan payable	1,104,000	979,000	[1]
Current portion of loans payable, net of discount of $966,767 and $1,651,597	19,403,219	9,918,389	[1]
Vehicle loan - current portion	38,522	38,522	[1]
Current portion of accrued interest payable	5,726,894	2,761,446	[1]
Total current liabilities	28,753,936	16,049,593	[1]
Non-current operating lease liability	901,321	950,541	[1]
Loans payable, net of discount of $4,654,370 and $4,130,291, respectively	7,175,990	15,554,069	[1]
Deferred variable payment obligation	2,525,000	2,525,000	[1]
Accrued interest payable	2,061,093	3,060,656	[1]
Total liabilities	41,417,340	38,139,859	[1]
Stockholders' deficit:
Preferred stock, value			[1]
Common Stock, $0.00001 par value; 10,000,000,000 shares authorized 7,039,806,793 and 5,848,741,599 shares issued, issuable and outstanding, respectively	70,399	58,489	[1]
Additional paid-in capital	87,445,715	80,247,252	[1]
Preferred stock to be issued	99,086	99,086	[1]
Accumulated deficit	(121,568,632)	(112,253,711)	[1]
Total stockholders' deficit	(33,947,549)	(31,843,001)	[1]
Total liabilities and stockholders' deficit	7,469,791	6,296,858	[1]
Series G Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value			[1]
Series E Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	3,350	3,350	[1]
Total stockholders' deficit	3,350	3,350
Series F Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	2,533	2,533	[1]
Total stockholders' deficit	$ 101,619	$ 101,619

[1] Derived from audited information

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Accumulated depreciation, revenue earning devices	$ 1,044,294	$ 779,839
Accumulated depreciation, fixed assets	276,530	182,002
Discount of current portion of loans payable	966,767	1,651,597
Discount of loans payable	$ 4,654,370	$ 4,130,291
Preferred stock, authorized	15,545,650	15,545,650
Preferred stock, shares outstanding	0	0
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per shares)	$ 0.00001	$ 0.00001
Common stock, authorized	10,000,000,000	10,000,000,000
Preferred stock, shares issued	7,039,806,793	5,848,741,599
Common stock, shares, outstanding	7,039,806,793	5,848,741,599
Series G Preferred Stock [Member]
Preferred stock, authorized	100,000	100,000
Preferred stock, shares outstanding	0	0
Preferred stock, shares issued	0	0
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001
Series E Preferred Stock [Member]
Preferred stock, authorized	4,350,000	4,350,000
Preferred stock, shares outstanding	3,350,000	3,350,000
Preferred stock, shares issued	3,350,000	3,350,000
Preferred stock, par value (in dollars per shares)	$ 0.001	$ 0.001
Series F Preferred Stock [Member]
Preferred stock, authorized	4,350	4,350
Preferred stock, shares outstanding	2,533	2,533
Preferred stock, shares issued	2,533	2,533
Preferred stock, par value (in dollars per shares)	$ 1.00	$ 1.00

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Income Statement [Abstract]
Revenues	$ 386,363	$ 267,484	$ 771,571	$ 652,641
Cost of Goods Sold	89,014	34,214	180,525	327,938
Gross Profit	297,349	233,270	591,046	324,703
Operating expenses:
Research and development (Note 10)	794,548	963,786	1,686,305	1,987,521
General and administrative	2,294,471	2,238,442	4,414,902	4,638,834
Depreciation and amortization	191,041	145,793	358,983	239,788
Operating lease cost and rent	62,541	63,681	125,083	133,648
Total operating expenses	3,342,601	3,411,702	6,585,273	6,999,791
Loss from operations	(3,045,252)	(3,178,432)	(5,994,227)	(6,675,088)
Other income (expense), net:
Change in fair value of derivative liabilities		3,595		3,595
Interest expense	(1,753,216)	(1,002,020)	(3,359,432)	(2,177,050)
Gain (loss) on settlement of debt	38,740	3,992	38,740	3,992
Total other expense net	(1,714,476)	(994,433)	(3,320,692)	(2,169,463)
Net loss	$ (4,759,728)	$ (4,172,865)	$ (9,314,919)	$ (8,844,551)
Net loss per share - basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Net loss per share - diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common share outstanding - basic	6,568,957,612	4,970,040,852	6,266,833,467	4,884,349,362
Weighted average common share outstanding - diluted	6,568,957,612	4,970,040,852	6,266,833,467	4,884,349,362

XML

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)	Series E Preferred Stock [Member]	Series F Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Feb. 28, 2022	$ 3,350	$ 101,618	$ 47,353	$ 73,015,576	$ (94,144,254)	$ (20,976,357)
Beginning balance, (in shares) at Feb. 28, 2022	3,350,000	2,532	4,735,210,360
Issuance of shares, net of $176,672 issuance costs			$ 1,339	1,643,883		1,645,222
Issuance of shares, net of issuance costs (in shares)			133,881,576
Rounding				(1)		(1)
Net income					(4,671,686)	(4,671,686)
Ending balance, (in shares) at May. 31, 2022	3,350,000		4,869,091,936
Ending balance, value at May. 31, 2022	$ 3,350	101,618	$ 48,692	74,659,458	(98,815,940)	(24,002,822)
Beginning balance, value at Feb. 28, 2022	$ 3,350	$ 101,618	$ 47,353	73,015,576	(94,144,254)	(20,976,357)
Beginning balance, (in shares) at Feb. 28, 2022	3,350,000	2,532	4,735,210,360
Net income						(8,844,551)
Ending balance, (in shares) at Aug. 31, 2022	3,350,000	2,532	5,063,354,356
Ending balance, value at Aug. 31, 2022	$ 3,350	$ 101,618	$ 50,635	74,111,156	(102,988,805)	(28,722,046)
Beginning balance, value at May. 31, 2022	$ 3,350	101,618	$ 48,692	74,659,458	(98,815,940)	(24,002,822)
Beginning balance, (in shares) at May. 31, 2022	3,350,000		4,869,091,936
Issuance of shares, net of $176,672 issuance costs			$ 1,917	1,889,350		1,891,267
Issuance of shares, net of issuance costs (in shares)			191,691,135
Net income					(4,172,865)	(4,172,865)
Cashless exercise of warrants			$ 97	(97)
Cashless exercise of warrants (in shares)			9,688,179
Relative fair value of warrants issued with debt				404,374		404,374
Cancelled shares			$ (171)	171
Cancelled Shares (in shares)			(17,116,894)
Exchange of 955,000,000 warrants for debt				(2,960,500)		(2,960,500)
Shares as payment for services			$ 100	118,400		118,500
Ending balance, (in shares) at Aug. 31, 2022	3,350,000	2,532	5,063,354,356
Shares as payment for services (in shares)			10,000,000
Ending balance, value at Aug. 31, 2022	$ 3,350	$ 101,618	$ 50,635	74,111,156	(102,988,805)	(28,722,046)
Beginning balance, value at Feb. 28, 2023	$ 3,350	$ 101,619	$ 58,489	80,247,252	112,253,711	(31,843,001)	[1]
Beginning balance, (in shares) at Feb. 28, 2023	3,350,000	2,533	5,848,741,599
Issuance of shares, net of $176,672 issuance costs			$ 2,809	1,316,100		1,318,909
Issuance of shares, net of issuance costs (in shares)			280,929,190
Net income					4,555,193	(4,555,193)
Ending balance, (in shares) at May. 31, 2023	3,350,000		6,129,670,789
Ending balance, value at May. 31, 2023	$ 3,350	101,619	$ 61,298	82,563,520	116,808,904	(34,079,117)
Relative fair value of Series F warrants issued with loans payable				947,447		947,447
Stock based compensation				52,721		52,721
Beginning balance, value at Feb. 28, 2023	$ 3,350	$ 101,619	$ 58,489	80,247,252	112,253,711	(31,843,001)	[1]
Beginning balance, (in shares) at Feb. 28, 2023	3,350,000	2,533	5,848,741,599
Net income						(9,314,919)
Ending balance, (in shares) at Aug. 31, 2023	3,350,000	2,533	7,039,806,793
Shares as payment for services (in shares)			6,500,000
Ending balance, value at Aug. 31, 2023	$ 3,350	$ 101,619	$ 70,399	87,445,715	(121,568,632)	(33,947,549)
Beginning balance, value at May. 31, 2023	$ 3,350	101,619	$ 61,298	82,563,520	116,808,904	(34,079,117)
Beginning balance, (in shares) at May. 31, 2023	3,350,000		6,129,670,789
Issuance of shares, net of $176,672 issuance costs			$ 9,036	4,787,087		4,796,123
Issuance of shares, net of issuance costs (in shares)			903,636,004
Net income					(4,759,728)	(4,759,728)
Shares as payment for services			$ 65	44,395		44,460
Ending balance, (in shares) at Aug. 31, 2023	3,350,000	2,533	7,039,806,793
Ending balance, value at Aug. 31, 2023	$ 3,350	$ 101,619	$ 70,399	87,445,715	(121,568,632)	(33,947,549)
Stock based compensation				$ 50,713		$ 50,713

[1] Derived from audited information

XML

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' DEFICIT (Unaudited) (Parenthetical) - USD ($)	3 Months Ended
	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022
Statement of Stockholders' Equity [Abstract]
Issuance cost of shares	$ 176,672	$ 81,285	$ 95,293	$ 117,157

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
CASH FLOWS USED IN OPERATING ACTIVITIES:
Net loss	$ (9,314,919)	$ (8,844,551)
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	358,983	239,786
Bad debts expense	24,730	145,000
Inventory provision		70,000
Reduction of right of use asset	58,220	56,854
Accretion of lease liability	66,864	72,090
Stock based compensation	228,434	343,000
Change in fair value of derivative liabilities		(3,595)
Amortization of debt discounts	1,258,198	671,594
Increase in related party accrued payroll and interest	54,230	6,480
Changes in operating assets and liabilities:
Accounts receivable	(20,377)	(158,183)
Prepaid expenses	(77,410)	(23,984)
Device parts inventory	(941,261)	(632,760)
Accounts payable and accrued expenses	16,775	351,014
Customer deposits	24,798	(8,128)
Operating lease liabilities	(125,083)	(128,944)
Current portion of deferred variable payment obligation for payments	125,457	106,120
Accrued interest payable	1,965,885	987,737
Net cash used in operating activities	(6,335,216)	(6,754,462)
CASH FLOWS USED IN INVESTING ACTIVITIES:
Purchase of fixed assets	(3,463)	(207,197)
Net cash used in investing activities	(3,463)	(207,197)
CASH FLOWS FROM FINANCING ACTIVITIES:
Share proceeds net of issuance costs	6,115,032	3,255,289
Proceeds from loans payable	1,050,000	500,000
Repayment of loans payable	(254,000)	(1,697,953)
Proceeds from convertible debt and warrants issued		619,250
Net cash provided by financing activities	6,911,032	2,676,586
Net change in cash	572,353	(4,285,073)
Cash, beginning of period	939,759	4,648,146
Cash, end of period	1,512,112	363,073
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	9,892	405,117
Cash paid for income taxes
Noncash investing and financing activities:
Transfer from device parts inventory to revenue earning devices	889,230	452,526
Discount applied to face value of loans	150,000	39,500
Series F warrants issued as part of debt	$ 947,447

XML

GENERAL INFORMATION

6 Months Ended

Aug. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GENERAL INFORMATION

1. GENERAL INFORMATION

Artificial Intelligence Technology Solutions Inc. (“AITX” or the “Company”) was incorporated in Florida on March 25, 2010 and reincorporated in Nevada on February 17, 2015. On August 24, 2018, Artificial Intelligence Technology Solutions Inc., changed its name from On the Move Systems Corp (“OMVS”).

Robotic Assistance Devices, LLC (“RAD”), was incorporated in the State of Nevada on July 26, 2016 as a Limited Liability Company. On July 25, 2017, Robotic Assistance Devices LLC converted to a C Corporation, Robotic Assistance Devices, Inc., through the issuance of 10,000 common shares to its sole shareholder.

On August 28, 2017, AITX completed the acquisition of RAD (the “Acquisition”), whereby AITX acquired all the ownership and equity interest in RAD for 3,350,000 shares of AITX Series E Preferred Stock and 2,450 shares of Series F Convertible Preferred Stock. AITX’s prior business focus was transportation services, and was exploring the on-demand logistics market by developing a network of logistics partnerships. As a result of the closing of the Acquisition, AITX has succeeded to the business of RAD, and AITX’s business going forward will consist of one segment activity, which is the delivery of artificial intelligence and robotic solutions for operational, security and monitoring needs.

The Acquisition was treated as a reverse recapitalization effected by a share exchange for financial accounting and reporting purposes since substantially all of AITX’s operations were disposed of as part of the consummation of the transaction. Therefore, no goodwill or other intangible assets were recorded by AITX as a result of the Acquisition. RAD is treated as the accounting acquirer as its stockholders control the Company after the Acquisition, even though AITX was the legal acquirer.  As a result, the assets and liabilities and the historical operations that are reflected in these financial statements are those of RAD as if RAD had always been the reporting company.

XML

GOING CONCERN

6 Months Ended

Aug. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

GOING CONCERN

2. GOING CONCERN

The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

For the six months ended August 31, 2023, the Company had negative cash flow from operating activities of $6,335,216. As of August 31, 2023, the Company has an accumulated deficit of $121,568,632, and negative working capital of $24,615,965. Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of these financial statements.

The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.

Management has plans to address the Company’s financial situation as follows:

Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. In March 2023, the Company entered into an equity financing agreement whereby an investor will purchase up to $12,500,000 of the Company’s common stock at a discount over a two-year period.   In March and April 2023 the Company reduced personnel that were working on far-future solutions as well as other department reductions. Combined with other cost cutting measures management estimates it reduced the monthly expense burn by $ 200,000 - $ 300,000 with little impact on short and medium term operations. Management believes that it has the necessary support to continue operations by continuing its funding methods in the following ways : growing revenues ,equity proceeds and non-convertible debt. Management has had many recent conversations with the Company’s primary debt holder and believes that the non-convertible debt on the balance sheet will be extended. Management notes that non-convertible debt on the books has been extended by this debt holder twice in the past and notes that this debt holder has been a strong supporter of the Company.

Management is committed to raise either non-dilutive funds or minimally dilutive funds. There is no assurance that these funds will be able to be raised nor can we provide assurance that these possible raises may not have dilutive effects. The Company this fiscal quarter through to September 26, 2023 has raised an additional $5.2 million net of issuance costs through the sale of its common shares.

XML

ACCOUNTING POLICIES

6 Months Ended

Aug. 31, 2023

Accounting Policies [Abstract]

ACCOUNTING POLICIES

3. ACCOUNTING POLICIES

Basis of Presentation and Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 14, 2023. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the six months ended August 31, 2023 are not necessarily indicative of the results that may be expected for the entire year.

Use of Estimates

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.

Concentrations

Loans payable

At August 31, 2023 there were $32,200,345 of loans payable, $27,890,506 or 87% of these loans to companies controlled by one individual. At February 28, 2023 there were $31,254,345 of loans payable $26,540,506 or 85% of these loans to companies controlled by the same individual.

Cash

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

Accounts Receivable

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $59,000 and $39,000 provided as of August 31, 2023 and February 28, 2023, respectively. For the three months ended August 31, 2023 , two customers account for 37% of total accounts receivable . For the three months ended August 31, 2022 , four customers account for 54% of total accounts receivable.

Device Parts Inventory

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development.  A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of August 31, 2023 and February 28, 2023 there was a valuation reserve of $195,000 and $195,000, respectively.

Revenue Earning Devices

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

Fixed Assets

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

Computer equipment and software	2 or 3 years
Office equipment	4 years
Manufacturing equipment	7 years
Warehouse equipment	5 years
Tooling	2 years
Demo Devices	4 years
Vehicles	3 years
Leasehold improvements	5 years, the life of the lease

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

Research and Development

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At August 31, 2023 and February 28, 2023, the Company had no deferred development costs.

Contingencies

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

Sales of Future Revenues

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

● Does the agreement purport, in substance, to be a sale

● Does the Company have continuing involvement in the generation of cash flows due the investor

● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets

● Is the investors rate of return is implicitly limited by the terms of the agreement

● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return

● Does the investor have recourse relating to payments due

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

Revenue Recognition

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the six months ended August 31, 2023 , two customers accounted for 33% of total revenue (2022- 26%).

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements

Leases

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

Distinguishing Liabilities from Equity

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

Initial Measurement

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

Subsequent Measurement – Financial Instruments Classified as Liabilities

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 – Inputs that are unobservable for the asset or liability.

Measured on a Recurring Basis

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

			Fair Value Measurement Using
	Amount at Fair Value		Level 1		Level 2		Level 3
August 31, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	1,104,000	$	—	$	—	$	1,104,000
February 28, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	979,000	$	—	$	—	$	979,000

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

Earnings (Loss) per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. Adoption of the standard requires using either a modified retrospective or a full retrospective approach. Management is currently evaluating the effect of these provisions on the Company’s financial position and results of operations.

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS

6 Months Ended

Aug. 31, 2023

Revenue from Contract with Customer [Abstract]

REVENUE FROM CONTRACTS WITH CUSTOMERS

4. REVENUE FROM CONTRACTS WITH CUSTOMERS

Revenue is earned primarily from two sources: 1) direct sales of goods or services and 2) short-term rentals. Direct sales of goods or services are accounted for under Topic 606, and short-term rentals are accounted for under Topic 842 (which addresses lease accounting and was adopted on March 1, 2019).

As disclosed in the revenue recognition section of Note 3 – Accounting Polices, the Company adopted Topic 606 in accordance with the effective date on March 1, 2018. Note 3 includes disclosures regarding the Company’s method of adoption and the impact on the Company’s financial statements. Revenue is recognized on direct sales of goods or services when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services.

After adopting Topic 842, also referred to above in Note 3, the Company is accounting for revenue earned from rental activities where an identified asset is transferred to the customer and the customer has the ability to control that asset. The Company recognizes revenue from its device rental activities when persuasive evidence of a contract exists, the performance obligations have been satisfied, the transaction price is fixed or determinable and collection is reasonably assured. Performance obligations associated with device rental transactions are satisfied over the rental period. Rental periods are short-term in nature. Therefore, the Company has elected to apply the practical expedient which eliminates the requirement to disclose information about remaining performance obligations. Payments are due from customers at the completion of the rental, except for customers with negotiated payment terms, generally net 30 days or less, which are invoiced and remain as accounts receivable until collected.

The following table presents revenues from contracts with customers disaggregated by product/service:

	Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	August 31, 2023		August 31, 2022		August 31, 2023		August 31, 2022
Device rental activities	$	343,543	$	228,214	$	581,692	$	468,019
Direct sales of goods and services		42,820		39,270		189,879		184,622
	$	386,363	$	267,484	$	771,571		652,641

XML

LEASES

6 Months Ended

Aug. 31, 2023

Leases

LEASES

5. LEASES

We lease certain warehouses, and office space. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic 842, we did not combine lease and non-lease components.

There is no lease renewal. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.

Below is a summary of our lease assets and liabilities at August 31, 2023 and February 28, 2023.

Leases	Classification	August 31, 2023		February 28, 2023
Assets
Operating	Operating Lease Assets	$	1,148,682	$	1,208,440
Liabilities
Current
Operating	Current Operating Lease Liability	$	239,669	$	248,670
Noncurrent
Operating	Noncurrent Operating Lease Liabilities		901,321		950,541
Total lease liabilities		$	1,140,990	$	1,199,211

Note: As most of our leases do not provide an implicit rate, we use our incremental borrowing rate of 10% which for the leases noted above was based on the information available at commencement date in determining the present value of lease payments. We compare against loans we obtain to acquire physical assets and not loans we obtain for financing. The loans we obtain for financing are generally at significantly higher rates and we believe that physical space or vehicle rental agreements are in line with physical asset financing agreements. CAM charges were not included in operating lease expense and were expensed in general and administrative expenses as incurred.

Rent expense and operating lease cost was $62,541 and $125,083 for the three and six months ended August 31, 2023, respectively, and $63,681 and $133,648 for the three and six months ended August 31, 2022, respectively.

XML

REVENUE EARNING DEVICES

6 Months Ended

Aug. 31, 2023

Revenue Earning Devices

REVENUE EARNING DEVICES

6. REVENUE EARNING DEVICES

Revenue earning devices consisted of the following:

	August 31, 2023			February 28, 2023
Revenue earning devices	$	2,800,522		$	2,015,058
Less: Accumulated depreciation		(1,044,294	)		(779,839	)
	$	1,756,228		$	1,235,219

During the three and six months ended August 31, 2023 the Company made total additions to revenue earning devices of $341,042 and $785,464, respectively, which were transfers from inventory. During the three and six months ended August 31, 2022 the Company made total additions to revenue earning devices of $251,946 and $426,047, respectively, which were transfers from inventory.

Depreciation expense was $141,614 and $264,455 for the three and six months ended August 31, 2023, respectively, and $116,125 and $187,539 for the three and six months ended August 31, 2022, respectively.

XML

FIXED ASSETS

6 Months Ended

Aug. 31, 2023

Property, Plant and Equipment [Abstract]

FIXED ASSETS

7. FIXED ASSETS

Fixed assets consisted of the following:

	August 31, 2023			February 28, 2023
Automobile	$	101,680		$	101,680
Demo devices		172,778			69,010
Tooling		101,322			101,322
Machinery and equipment		8,825			8,825
Computer equipment		150,387			150,387
Office equipment		15,312			15,312
Furniture and fixtures		21,225			21,225
Warehouse equipment		14,561			14,561
Leasehold improvements		19,031			15,568
		605,121			497,890
Less: Accumulated depreciation		(276,530	)		(182,002	)
	$	328,591		$	315,888

During the three months ended August 31, 2023, the Company made additions of $75,057 which were transfers from inventory. During the six months ended August 31, 2023, the Company made additions of $107,230 of which $103,767 were transfers from inventory with remaining additions of $3,463. During the three months ended August 31, 2022, the Company made additions of $139,946 of which $20,693 were transfers from inventory with remaining additions of $118,983. During the six months ended August 31, 2022, the Company made additions of $233,676 of which $26,479 were transfers from inventory with remaining additions of $207,197.

Depreciation expense was $49,427 and $94,528 for the three and six months ended August 31, 2023, respectively, and $29,668 and $52,249 for the three and six months ended August 31, 2022, respectively.

XML

DEFERRED VARIABLE PAYMENT OBLIGATION

6 Months Ended

Aug. 31, 2023

Deferred Variable Payment Obligation

DEFERRED VARIABLE PAYMENT OBLIGATION

8. DEFERRED VARIABLE PAYMENT OBLIGATION

On February 1, 2019 the Company entered into an agreement with an investor whereby the investor would pay up to $900,000 in exchange for a perpetual 9% rate payment (Payments) on the Company’s reported quarterly revenue from operations excluding any gains or losses from financial instruments (Revenues). At February 29, 2020 the investor has advanced the full $900,000.

On May 9, 2019 the Company entered into two similar arrangements with two investors:

(1)	The investor would pay up to $400,000 in exchange for a perpetual 4% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $400,000 has been paid to the Company.
(2)	The investor would pay up to $50,000 in exchange for a perpetual 1.11% rate Payment on the Company’s reported quarterly Revenues. At February 29, 2020, $50,000 has been paid to the Company.

These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.

In the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 30% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.

On November 18, 2019, the Company entered into another similar arrangement with the (February 1, 2019) investor above whereby the investor would advance up to $225,000 in exchange for a perpetual 2.25% rate Payment on the Company’s quarterly Revenues (commencing on quarter ending May 31, 2020). At February 29, 2020, the investor has advanced $109,000 and the investor advanced the $116,000 remainder as of May 2020.

On December 30, 2019, the Company entered into another similar arrangement with a new investor whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues (commencing quarter ended November 30, 2020). At February 29, 2020, the investor has advanced $50,000 with the remainder to be advanced no later than June 30, 2020. If the total investor advances turns out to be less than $100,000, this would not constitute a breach of the agreement, rather the 1.00% rate would be adjusted on a pro-rata basis.

On April 22, 2020, the Company entered into another similar arrangement with the (first May 9, 2019) investor above whereby the investor would advance up to $100,000 in exchange for a perpetual 1.00% rate Payment on the Company’s quarterly Revenues. At May 31, 2020, the investor has fully funded this commitment.

On July 1, 2020, the Company entered into a similar agreement with the first investor whereby the investor would pay up to $800,000 in exchange for a perpetual 2.75% rate payment (Payment) on the Company’s reported quarterly revenue. These Payments are to be made 90 days after the fiscal quarter with the first payment being due no later than May 31, 2021. If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.

On August 27, 2020, the Company and the first investor referred to above consolidated the three separate agreements of February 1, 2019 for $900,000, November 18, 2019 for $225,000 and July 1, 2020 for $800,000 into a new agreement for a total of $1,925,000. This new agreement is for similar terms as the above agreements save for the following: the rate payment is revised to 14.25% payable on revenues commencing the quarter ended August 31, 2020. Upon an event of default that we are unable to cure in the time allotted under the agreements, these Payments may be secured with a priority lien by UCC filing against all of our assets, but is subordinated to equipment financing or leasing agreements on the products the Company leases to its customers.

In summary of all agreements mentioned above if in the event that at least 10% of the assets of the Company are sold by the Company, the investors would be entitled to the fair market value (FMV) of all future Payments associated with the assets sold as determined by an independent valuator to be chosen by the investors. The FMV cannot exceed 43.77% of the total asset disposition price defined as the total price paid for the assets plus all future Payments associated with the assets sold. In the event that the common or preferred shares are sold by the Company to a third party as to effect a change in control, then the investors must be paid the FMV of all future Payments in one lump payment. The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.

The Payments first become payable on June 30, 2019 (unless otherwise indicated) based on the quarterly Revenues for the quarter ended May 31, 2019 and accrue every quarter thereafter. As of August 31, 2023, the Company has accrued $667,634 in Payments of which $431,719 are in arrears. As of February 28, 2023, the Company has accrued $542,177 in Payments of which $325,600 are in arrears. No notices have been sent to the Company.

On March 1, 2021, the first investor referred to above whose aggregate investment is $1,925,000 revised his agreements as follows:

1)	The rate payment was reduced from 14.25 % to 9.65 %
2)	The asset disposition % (see below) was reduced from 31 % to 21%

In consideration for the above changes, the investor received 40 Series F Convertible Preferred Stock and a warrant to purchase 367 shares of its Series F Convertible Preferred Stock with a five-year term and an exercise price of $1.00. During the three months ended May 31, 2021, the warrant holder exercised warrants to acquire 38 shares of Series F Convertible Preferred Stock. The Company attributed a fair value based on recent transactions for the Series F Preferred stock and warrants of $33,015,214 and recorded a loss on settlement of debt with a corresponding adjustment to paid in capital.

The Company retains total involvement in the generation of cash flows from these revenue streams that form the basis of the payments to be made to the investors under this agreement. Because of this, the Company has determined that the agreements constitute debt agreements. As of August 31, 2023, and February 28, 2023, the long-term balances other than Payments already owed is the cash received of $2,525,000 and $2,525,000, respectively.

For both the three months and six months ended August 31, 2023 and year ended February 28, 2023, the Company has received $0 related to the deferred payment obligation since there were no new agreements during this period. The balance remains $2,525,000 at both August 31, 2023 and February 28, 2023.

XML

RELATED PARTY TRANSACTIONS

6 Months Ended

Aug. 31, 2023

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

9. RELATED PARTY TRANSACTIONS

For both the three months ended August 31, 2023 and August 31, 2022 , the Company had no repayments of net advances from its loan payable-related party At August 31, 2023, the loan payable-related party was $260,746 and $206,516 at February 28, 2023. Included in the balance due to the related party at August 31, 2023 is $172,265 of deferred salary and interest, $145,500 of which bears interest at 12%. At February 28, 2023, included in the balance due to the related party is $108,000 of deferred salary with $108,000 bearing interest at 12%. The accrued interest included in loan at August 31, 2023 and February 28, 2023 was $23,515 and $15,660 respectively.

Pursuant to the amended Employment Agreement with its Chief Executive Officer, for the three months and six ended August 31, 2023, the Company accrued $62,000 (2022-$63,000) and $125,000 (2022-$224,500) of incentive compensation plan payable with a corresponding recognition of stock based compensation due to the expectation of additional awards being met. This will be payable in Series G Preferred Shares which are redeemable at the Company’s option at $1,000 per share. At August 31, 2023 and February 28, 2023 there was $1,104,000 and $979,000 of incentive compensation payable.

During the three months ended August 31, 2023 and 2022, the Company was charged $777,260 and $957,395, respectively for fees for research and development from a company partially owned by a principal shareholder.

During the six months ended August 31, 2023 and 2022, the Company was charged $1,659,275 and $1,959,129, respectively for fees for research and development from a company partially owned by a principal shareholder.

XML

OTHER DEBT – VEHICLE LOAN

6 Months Ended

Aug. 31, 2023

Other Debt Vehicle Loan

OTHER DEBT – VEHICLE LOAN

10. OTHER DEBT – VEHICLE LOAN

In December 2016, RAD entered into a vehicle loan for $47,704 secured by the vehicle. The loan is repayable over 5 years maturing November 9, 2021, and repayable $1,019 per month including interest and principal. In November 2017, RAD entered into another vehicle loan secured by the vehicle for $47,661. The loan is repayable over 5 years, maturing October 24, 2022 and repayable at $923 per month including interest and principal. The principal repayments made were $0 for both the year ended February 28, 2022 and February 28, 2021. Regarding the second vehicle loan, the vehicle was returned at the end of fiscal 2019 and the car was subsequently sold by the lender for proceeds of $21,907 which went to reduce the outstanding balance of the loan. A loss of $3,257 was recorded as well. A balance of $21,578 remains on this vehicle loan at both February 28, 2021 and February 29, 2020. For the first vehicle loan, the vehicle was retired in 2020, the proceeds of the disposal of $18,766 was applied against the balance of the loan with a $5,515 gain on the remaining asset value of $13,251. A balance of $16,944 remains on this vehicle loan at both February 28, 2022 and February 28, 2021. The remaining total balances of the amounts owed on the vehicle loans were $38,522 and $38,522 as of August 31, 2023 and February 28, 2023, respectively, of which all were classified as current.

XML

LOANS PAYABLE

6 Months Ended

Aug. 31, 2023

Loans Payable

LOANS PAYABLE

11. LOANS PAYABLE

Loans payable at August 31, 2023 consisted of the following:

							Annual
Date	Maturity	Description		Principal			Interest Rate
July 18, 2016	July 18, 2017	Promissory note	(1) *	$	3,500		22%
December 10, 2020	December 10, 2023	Promissory note	(2)		3,921,168		12%
December 10, 2020	December 10, 2023	Promissory note	(3)		3,054,338		12%
December 10, 2020	December 10, 2023	Promissory note	(4)		165,605		12%
December 14, 2020	December 14, 2023	Promissory note	(5)		310,375		12%
December 30, 2020	December 30, 2023	Promissory note	(6)		350,000		12%
January 1, 2021	January 1, 2024	Promissory note	(7)		25,000		12%
January 1, 2021	January 1, 2024	Promissory note	(8)		145,000		12%
January 14, 2021	January 14, 2024	Promissory note	(9)		550,000		12%
February 22, 2021	February 22, 2024	Promissory note	(10)		1,650,000		12%
March 1, 2021	March 1, 2024	Promissory note	(11)		6,000,000		12%
June 8, 2021	June 8, 2024	Promissory note	(12)		2,750,000		12%
July 12, 2021	July 26, 2026	Promissory note	(13)		3,830,360		7%
September 14, 2021	September 14, 2024	Promissory note	(14)		1,650,000		12%
July 28, 2022	July 28, 2023	Promissory note	(15)		—		15%
August 30, 2022	August 30,2024	Promissory note	(16)		3,000,000		15%
September 7, 2022	September 7, 2023	Promissory note	(17)		370,000		15%
September 8, 2022	September 8, 2023	Promissory note	(18)		475,000		15%
October 13, 2022	October 13, 2023	Promissory note	(19)		350,000		15%
October 28, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 9, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 10, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 15, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
January 11, 2023	October 31,2026	Promissory note	(20)		400,000		15%
February 6, 2023	October 31, 2026	Promissory note	(20)		400,000		15%
April 5. 2023	October 31, 2026	Promissory note	(20)		400,000		15%
April 20, 23	October 31, 2026	Promissory note	(20)		400,000		15%
May 11, 2023	October 31, 2026	Promissory note	(20)		400,000		15%
				$	32,200,346
Less: current portion of loans payable					(20,369,986	)
Less: discount on non-current loans payable					(4,654,370	)
Non-current loans payable, net of discount				$	7,175,990
Current portion of loans payable				$	20,369,986
Less: discount on current portion of loans payable					(966,767	)
Current portion of loans payable, net of discount				$	19,403,219

* In default

(1)	This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
(2)	This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(3)	This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(4)	This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.
(5)	This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.
(6)	The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $52,756 and $92,660, respectively, with an unamortized discount of $100,855 at August 31, 2023.
(7)	This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(8)	This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(9)	The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $62,143 and $113,188 respectively, with an unamortized discount of $126,148 at August 31, 2023.
(10)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $220,757 and $379,821 respectively, with an unamortized discount of $732,440 at August 31, 2023.

(11)	The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized.
(12)	The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $175,789 and $330,699 respectively, with an unamortized discount of $463,519 at August 31, 2023.
(13)	This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2023 there were repayments of  $27,000 and $54,000 . respectively on the note.
(14)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $115,344 and $202,274 respectively, with an unamortized discount of $1,27,501 at August 31, 2023.
(15)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $3,739 and $9,026 respectively, with an unamortized discount of $0 at August 31, 2023. This loan has been fully repaid.
(16)	A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $4,736 and $9,293 respectively, with an unamortized discount of $21,576 at August 31, 2023.
(17)	Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000.  Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $15,479 and $27,821 respectively, with an unamortized discount of $0 at August 31, 2023.
(18)	Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $17,799 and $36,729 respectively, with an unamortized discount of $0 at August 31, 2023.
(19)	Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $13,295 and $25,585 respectively, with an unamortized discount of $7,325 at August 31, 2023.

(20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At November 30, 2022 the Company has issued 6 tranches as follows:

October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,472 and $4,338 respectively, with an unamortized discount of $343,685 at August 31, 2023.

November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,438 and $4,276 respectively, with an unamortized discount of $344,162 at August 31, 2023.

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,233 and $3,900 respectively, with an unamortized discount of $346,981 at August 31, 2023.

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,489 and $4,370 respectively, with an unamortized discount of $343,445 at August 31, 2023.

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,541 and $4,565 respectively, with an unamortized discount of $342,724 at August 31, 2023.

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,436 and $4,272 respectively, with an unamortized discount of $344,154 at August 31, 2023.

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,523 and $3,274 respectively, with an unamortized discount of $342,971 at August 31, 2023.

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,010 and $2,206 respectively, with an unamortized discount of $350,013 at August 31, 2023.

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $0 and $0 respectively, with an unamortized discount of $398,983 at August 31, 2023.

XML

STOCKHOLDERS’ EQUITY (DEFICIT)

6 Months Ended

Aug. 31, 2023

Equity [Abstract]

STOCKHOLDERS’ EQUITY (DEFICIT)

13. STOCKHOLDERS’ EQUITY (DEFICIT)

Summary or Preferred Stock Activity

No preferred stock activity during the period.

Summary of Preferred Stock Warrant Activity

	Number of Series F Preferred Warrants	Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at March 1, 2023	695	$1.00	10.00
Issued	183	1.00	9.88
Exercised	—	—	—
Forfeited and cancelled	—	—	—
Outstanding at August 31, 2023	878	$1.00	9.75

During the six months ended August 31, 2023, as part of debt issuance the Company issued 183 Series F Preferred Warrants to a lender for a relative fair value of $947,447. (see Note 11)

Summary of Common Stock Activity

The Company increased authorized common shares from 7,225,000,000 to 10,000,000,000 on August 30, 2023.

For the three months ended August 31, 2023, the Company issued 903,636,004 common shares with gross proceeds of $4,972,795 and net proceeds of $4,796,193 after issuance costs of $176,672. For the six months ended August 31, 2023, the Company issued 1,184,565,194 common shares with gross proceeds of $6,372,989 and net proceeds of $6,115,032 after issuance costs of $257,956. In addition for the three and six months ended the Company issued 6,500,000 shares with a fair value of $ 44,460 as payment for services of $ 83,200. A gain on settlement of debt of $38,640 has been recorded. The Company also issued 12,100,000 previously recorded as issuable shares pursuant to agreements.

The table below represent the common shares issued, issuable and outstanding at August 31, 2023 and February 28, 2023:

Common shares	August 31, 2023		February 28, 2023
Issued		7,039,806,793		5,836,641,599
Issuable		—		12,100,000
Issued, issuable and outstanding		7,039,806,793		5,848,741,599

Summary of Common Stock Warrant Activity

For the three months and six months ended August 31, 2023 and August 31, 2022, the Company recorded a total of $50,713 and $0, and $103,434 and $0 respectively, to stock-based compensation for options and warrants with a corresponding adjustment to additional paid-in capital.

	Number of Warrants	Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at February 28, 2023	314,217,451	$0.114	1.95
Issued	—	—	—
Exercised	—	—	—
Forfeited and cancelled	—	—	—
Outstanding at August 31, 2023	314,217,451	$0.114	1.45

Summary of Common Stock Option Activity -Employee Stock Options

	Number of Options		Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at February 28 , 2023	95,725,000		$0.02	4.75
Issued	—		—	—
Exercised	—		—	—
Forfeited, extinguished and cancelled	(13,025,000	)	$0.02	(4.75)
Outstanding at August 31, 2023	82,700,000		$0.02	4.25

XML

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Aug. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

15. COMMITMENTS AND CONTINGENCIES

Litigation

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s condensed consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

The related legal costs are expensed as incurred.

Operating Lease

On December 18, 2020, the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E, Irvine CA, 92614, commencing on December 18, 2020 through to March 31, 2022 with a minimum base rent of $3,859 per month. The Company paid a security deposit of $3,859.

On March 10, 2021, the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month. The base rent increase by 3% per annum commencing May 1, 2024. The Company paid a security deposit of $15,880.

On September 30, 2021, the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month. The Company paid a down payment of $18,462.

On January 28, 2022, the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month. The Company paid a security deposit of $1,500.

The Company’s leases are accounted for as operating leases. Rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. Rent expense and operating lease cost was $62,541 and $125,083 for the three and six months ended August 31, 2023, respectively, and $63,681 and $133,648 for the three and six months ended August 31, 2022, respectively.

Maturity of Lease Liabilities	Operating Leases
August 31, 2024	$	239,669
August 31, 2025		207,558
August 31, 2026		207,558
August 31, 2027		207,558
August 31, 2028		207,558
August 31, 2029 and after		553,488
Total lease payments		1,623,389
Less: Interest		(482,399	)
Present value of lease liabilities	$	1,140,990

XML

EARNINGS (LOSS) PER SHARE

6 Months Ended

Aug. 31, 2023

Earnings Per Share [Abstract]

EARNINGS (LOSS) PER SHARE

16. EARNINGS (LOSS) PER SHARE

The net income (loss) per common share amounts were determined as follows:

	For the Three Months Ended						For the Six Months Ended
	August 31,						August 31,
	2023			2022			2023			2022
Numerator:
Net income (loss) available to common shareholders	$	(4,759,728	)	$	(4,172,865	)	$	(9,314,919	)	$	(8,844,551	)
Effect of common stock equivalents
Add: interest expense on convertible debt		—			8,543			—			8,737
Add (less) loss (gain) on settlement of debt		—			(3,992	)		—			(3,992	)
Add (less) loss (gain) on change of derivative liabilities		—			(3,595	)		—			(3,595	)
Net income (loss) adjusted for common stock equivalents		(4,759,728	)		(4,171,909	)		(9,314,919	)		(8,843,401	)
Denominator:
Weighted average shares – basic		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362
Net income (loss) per share – basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)
Dilutive effect of common stock equivalents:
Convertible Debt		—			—			—			—
Preferred shares		—			—			—			—
Warrants		—			—			—			—
		—			—			—			—
Denominator:
Weighted average shares – diluted		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362
Net income (loss) per share – diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)

The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2023 and 2022 were as follows:

	For the Three Months Ended				For the Six Months Ended
	August 31,				August 31,
	2023		2022		2023		2022
Convertible notes and accrued interest		—		836,425,685		—		836,425,685
Convertible Series F Preferred Shares		24,286,988,436		—		24,286,988,436		—
Stock options and warrants		433,767,451		401,217,451		433,767,451		401,217,451
Total		24,720,755,887		1,237,643,136		24,720,755,887		1,237,643,136

* On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at August 31, 2023 and 2022 the dilutive effects would be as follows:

	For the Three and Six Months Ended
	August 31, 2023	August 31, 2022
Convertible Series F Preferred Shares	—	17,375,422,528

XML

SUBSEQUENT EVENTS

6 Months Ended

Aug. 31, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

17. SUBSEQUENT EVENTS

Subsequent to August 31, 2023 through to October 12, 2023:

—   The Company issued 120,905,263 common shares pursuant to a share purchase agreement for gross proceeds of $377,224, issuance costs of $8,569 and net proceeds of $368,655.

XML

ACCOUNTING POLICIES (Policies)

6 Months Ended

Aug. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation and Consolidation

Basis of Presentation and Consolidation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and in conformity with the condensing instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”) and should be read in conjunction with the audited financial statements and notes thereto in the Company’s latest Annual Report filed with the SEC on Form 10-K as filed on June 14, 2023. The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Robotic Assistance Devices, Inc., Robotic Assistance Devices Group , Inc, Robotic Assistance Devices Mobile, Inc., On the Move Experience, LLC and On the OMV Transports, LLC. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited consolidated financial statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the six months ended August 31, 2023 are not necessarily indicative of the results that may be expected for the entire year.

Use of Estimates

Use of Estimates

In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgements and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to value preferred stock and derivative liabilities.

Concentrations

Concentrations

Loans payable

At August 31, 2023 there were $32,200,345 of loans payable, $27,890,506 or 87% of these loans to companies controlled by one individual. At February 28, 2023 there were $31,254,345 of loans payable $26,540,506 or 85% of these loans to companies controlled by the same individual.

Cash

Cash

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents consist of cash on deposit with banks and money market instruments. The Company places its cash and cash equivalents with high-quality, U.S. financial institutions and, to date has not experienced losses on any of its balances.

Accounts Receivable

Accounts Receivable

Accounts receivable are comprised of balances due from customers, net of estimated allowances for uncollectible accounts. In determining collectability, historical trends are evaluated, and specific customer issues are reviewed on a periodic basis to arrive at appropriate allowances. There was an allowance of $59,000 and $39,000 provided as of August 31, 2023 and February 28, 2023, respectively. For the three months ended August 31, 2023 , two customers account for 37% of total accounts receivable . For the three months ended August 31, 2022 , four customers account for 54% of total accounts receivable.

Device Parts Inventory

Device Parts Inventory

Device parts inventory is stated at the lower of cost or net realizable value using the weighted average cost method. The Company records a valuation reserve for obsolete and slow-moving inventory, relying principally on specific identification of such inventory. The Company uses these device parts in the assembly of revenue earning devices (and demo devices) as well as research and development. Depending on use, the Company will transfer the parts to the corresponding asset or expense if used in research and development.  A charge to income is taken when factors that would result in a need for an increase in the valuation, such as excess or obsolete inventory, are noted. As of August 31, 2023 and February 28, 2023 there was a valuation reserve of $195,000 and $195,000, respectively.

Revenue Earning Devices

Revenue Earning Devices

Revenue earning devices are stated at cost. Depreciation is provided on a straight-line basis over the estimated useful life of 48 months. The Company continually evaluates revenue earning devices to determine whether events or changes in circumstances have occurred that may warrant revision of the estimated useful life or whether the devices should be evaluated for possible impairment. The Company uses a combination of the undiscounted cash flows and market approaches in assessing whether an asset has been impaired. The Company measures impairment losses based upon the amount by which the carrying amount of the asset exceeds the fair value.

Fixed Assets

Fixed Assets

Fixed assets are stated at cost. Depreciation is provided on the straight-line method based on the estimated useful lives of the respective assets which range from two to five years. Major repairs or improvements are capitalized. Minor replacements and maintenance and repairs which do not improve or extend asset lives are expensed currently.

Computer equipment and software	2 or 3 years
Office equipment	4 years
Manufacturing equipment	7 years
Warehouse equipment	5 years
Tooling	2 years
Demo Devices	4 years
Vehicles	3 years
Leasehold improvements	5 years, the life of the lease

The Company periodically evaluates the fair value of fixed assets whenever events or changes in circumstances indicate that its carrying amounts may not be recoverable. Upon retirement or other disposition of fixed assets, the cost and related accumulated depreciation are removed from the accounts and the resulting gain or loss, if any, is recognized in income.

Research and Development

Research and Development

Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by Management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life or written off if a product is abandoned. At August 31, 2023 and February 28, 2023, the Company had no deferred development costs.

Contingencies

Contingencies

Occasionally, the Company may be involved in claims and legal proceedings arising from the ordinary course of its business. The Company records a provision for a liability when it believes that it is both probable that a liability has been incurred, and the amount can be reasonably estimated. If these estimates and assumptions change or prove to be incorrect, it could have a material impact on the Company’s consolidated financial statements. Contingencies are inherently unpredictable, and the assessments of the value can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions.

Sales of Future Revenues

Sales of Future Revenues

The Company has entered into transactions, as more fully described in footnote 8, in which it has received funding from investors in exchange for which it will make payments to those investors based on the level of sales of certain revenue categories, generally based on a percentage of sales for those certain revenues. The Company determines whether these agreements constitute sales of future revenues or are in substance debt based on the facts and circumstances of each agreement, with the following primary criteria determinative of whether the agreement constitutes a sale of future revenues or debt:

● Does the agreement purport, in substance, to be a sale

● Does the Company have continuing involvement in the generation of cash flows due the investor

● Is the transaction cancellable by either party through payment of a lump sum or other transfer of assets

● Is the investors rate of return is implicitly limited by the terms of the agreement

● Does the Company’s revenue for a reporting period underlying the agreement have only a minimal impact on the investor’s rate of return

● Does the investor have recourse relating to payments due

In the event a transaction is determined to be a sale of future revenues, it is recorded as deferred revenue and amortized using the sum-of-the-revenue method. In the event a transaction is determined to be debt, it is recorded as debt and amortized using the effective interest method. As of the date of these financial statements, the Company has determined that all such agreements are debt.

Revenue Recognition

Revenue Recognition

ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, supersedes the revenue recognition requirements and industry specific guidance under Revenue Recognition (Topic 605). Topic 606 requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. Topic 606 defines a five-step process that must be evaluated and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing accounting principles generally accepted in the United States of America (“U.S. GAAP”) including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. The Company adopted Topic 606 on March 1, 2018, using the modified retrospective method. Under the modified retrospective method, prior period financial positions and results will not be adjusted. There was no cumulative effect adjustment recognized as a result of this adoption. Refer to Note 4 – Revenue from Contracts with Customers for additional information. For the six months ended August 31, 2023 , two customers accounted for 33% of total revenue (2022- 26%).

Income Taxes

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized when items of income and expense are recognized in the financial statements in different periods than when recognized in the tax return. Deferred tax assets arise when expenses are recognized in the financial statements before the tax returns or when income items are recognized in the tax return prior to the financial statements. Deferred tax assets also arise when operating losses or tax credits are available to offset tax payments due in future years. Deferred tax liabilities arise when income items are recognized in the financial statements before the tax returns or when expenses are recognized in the tax return prior to the financial statements. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

On December 22, 2017, the Tax Cuts and Jobs Act (“Tax Act”) was signed into law. ASC 740, Accounting for Income Taxes requires companies to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2024, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements

Leases

Leases

Lease agreements are evaluated to determine if they are sales/finance leases meeting any of the following criteria at inception: (a) transfer of ownership of the underlying asset; (b) purchase option that is reasonably certain of being exercised; (c) the lease term is greater than a major part of the remaining estimated economic life of the underlying asset; or (d) if the present value of the sum of lease payments and any residual value guaranteed by the lessee that has not already been included in lease payments in accordance with ASC 842-10-30-5(f) equals or exceeds substantially all of the fair value of the underlying asset.

If at its inception, a lease meets any of the four lease criteria above, the lease is classified by the Company as a sales/finance; and if none of the four criteria are met, the lease is classified by the Company as an operating lease.

Operating lease payments are recognized as an expense in the income statement on a straight-line basis over the lease term, whereby an equal amount of rent expense is attributed to each period during the term of the lease, regardless of when actual payments are made. This generally results in rent expense in excess of cash payments during the early years of a lease and rent expense less than cash payments in the later years. The difference between rent expense recognized and actual rental payments is recorded as deferred rent and included in liabilities.

Distinguishing Liabilities from Equity

Distinguishing Liabilities from Equity

The Company relies on the guidance provided by ASC Topic 480, Distinguishing Liabilities from Equity, to classify certain redeemable and/or convertible instruments. The Company first determines whether a financial instrument should be classified as a liability. The Company will determine the liability classification if the financial instrument is mandatorily redeemable, or if the financial instrument, other than outstanding shares, embodies a conditional obligation that the Company must or may settle by issuing a variable number of its equity shares.

Once the Company determines that a financial instrument should not be classified as a liability, the Company determines whether the financial instrument should be presented between the liability section and the equity section of the balance sheet (“temporary equity”). The Company will determine temporary equity classification if the redemption of the financial instrument is outside the control of the Company (i.e. at the option of the holder). Otherwise, the Company accounts for the financial instrument as permanent equity.

Our Chief Executive Officer/ Chairman holds sufficient shares of the Company’s voting preferred stock that give sufficient voting rights under the articles of incorporation and bylaws of the Company such that the CEO/ Chairman can at any time unilaterally vote to increase the number of authorized shares of common stock of the Company, without the need to call a general meeting of common shareholders of the Company.

Initial Measurement

The Company records its financial instruments classified as liability, temporary equity or permanent equity at issuance at the fair value, or cash received.

Subsequent Measurement – Financial Instruments Classified as Liabilities

The Company records the fair value of its financial instruments classified as liabilities at each subsequent measurement date. The changes in fair value of its financial instruments classified as liabilities are recorded as other income (expenses).

Fair Value of Financial Instruments

Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurements and Disclosures (“ASC Topic 820”) provides a framework for measuring fair value in accordance with generally accepted accounting principles.

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

● Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

● Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

● Level 3 – Inputs that are unobservable for the asset or liability.

Measured on a Recurring Basis

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

			Fair Value Measurement Using
	Amount at Fair Value		Level 1		Level 2		Level 3
August 31, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	1,104,000	$	—	$	—	$	1,104,000
February 28, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	979,000	$	—	$	—	$	979,000

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepaid expenses and advances, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments.

Earnings (Loss) per Share

Earnings (Loss) per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS give effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used to determine the number of shares assumed to be purchased from the exercise of stock options and/or warrants. Diluted EPS excluded all dilutive potential shares if their effect is anti-dilutive.

Basic loss per common share is computed based on the weighted average number of shares outstanding during the period. Diluted loss per share is computed in a manner similar to the basic loss per share, except the weighted-average number of shares outstanding is increased to include all common shares, including those with the potential to be issued by virtue of convertible debt and other such convertible instruments. Diluted loss per share contemplates a complete conversion to common shares of all convertible instruments only if they are dilutive in nature with regards to earnings per share.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

Recently Issued Accounting Standards Not Yet Adopted

In August 2020, the FASB issued ASU 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. Under ASU 2020-06, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, or that do not result in substantial premiums accounted for as paid-in capital. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments. The amendments in ASU 2020-06 are effective for public entities, excluding smaller reporting companies as defined, for fiscal years beginning after December 15, 2021. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. A reporting entity is not permitted to adopt the guidance in an interim period, other than the first interim period of its fiscal year. Adoption of the standard requires using either a modified retrospective or a full retrospective approach. Management is currently evaluating the effect of these provisions on the Company’s financial position and results of operations.

XML

ACCOUNTING POLICIES (Tables)

6 Months Ended

Aug. 31, 2023

Accounting Policies [Abstract]

Fixed assets consisted of the following:

Computer equipment and software	2 or 3 years
Office equipment	4 years
Manufacturing equipment	7 years
Warehouse equipment	5 years
Tooling	2 years
Demo Devices	4 years
Vehicles	3 years
Leasehold improvements	5 years, the life of the lease

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell:

			Fair Value Measurement Using
	Amount at Fair Value		Level 1		Level 2		Level 3
August 31, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	1,104,000	$	—	$	—	$	1,104,000
February 28, 2023
Liabilities
Incentive compensation plan payable- revaluation of equity awards payable in Series G shares	$	979,000	$	—	$	—	$	979,000

XML

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)

6 Months Ended

Aug. 31, 2023

Revenue from Contract with Customer [Abstract]

The following table presents revenues from contracts with customers disaggregated by product/service:

The following table presents revenues from contracts with customers disaggregated by product/service:

	Three Months Ended		Three Months Ended		Six Months Ended		Six Months Ended
	August 31, 2023		August 31, 2022		August 31, 2023		August 31, 2022
Device rental activities	$	343,543	$	228,214	$	581,692	$	468,019
Direct sales of goods and services		42,820		39,270		189,879		184,622
	$	386,363	$	267,484	$	771,571		652,641

XML

LEASES (Tables)

6 Months Ended

Aug. 31, 2023

Leases

Below is a summary of our lease assets and liabilities at August 31, 2023 and February 28, 2023.

Below is a summary of our lease assets and liabilities at August 31, 2023 and February 28, 2023.

Leases	Classification	August 31, 2023		February 28, 2023
Assets
Operating	Operating Lease Assets	$	1,148,682	$	1,208,440
Liabilities
Current
Operating	Current Operating Lease Liability	$	239,669	$	248,670
Noncurrent
Operating	Noncurrent Operating Lease Liabilities		901,321		950,541
Total lease liabilities		$	1,140,990	$	1,199,211

XML

REVENUE EARNING DEVICES (Tables)

6 Months Ended

Aug. 31, 2023

Revenue Earning Devices

Revenue earning devices consisted of the following:

Revenue earning devices consisted of the following:

	August 31, 2023			February 28, 2023
Revenue earning devices	$	2,800,522		$	2,015,058
Less: Accumulated depreciation		(1,044,294	)		(779,839	)
	$	1,756,228		$	1,235,219

XML

FIXED ASSETS (Tables)

6 Months Ended

Aug. 31, 2023

Property, Plant and Equipment [Abstract]

Fixed assets consisted of the following:

Fixed assets consisted of the following:

	August 31, 2023			February 28, 2023
Automobile	$	101,680		$	101,680
Demo devices		172,778			69,010
Tooling		101,322			101,322
Machinery and equipment		8,825			8,825
Computer equipment		150,387			150,387
Office equipment		15,312			15,312
Furniture and fixtures		21,225			21,225
Warehouse equipment		14,561			14,561
Leasehold improvements		19,031			15,568
		605,121			497,890
Less: Accumulated depreciation		(276,530	)		(182,002	)
	$	328,591		$	315,888

XML

LOANS PAYABLE (Tables)

6 Months Ended

Aug. 31, 2023

Loans Payable

Loans payable at August 31, 2023 consisted of the following:

Loans payable at August 31, 2023 consisted of the following:

							Annual
Date	Maturity	Description		Principal			Interest Rate
July 18, 2016	July 18, 2017	Promissory note	(1) *	$	3,500		22%
December 10, 2020	December 10, 2023	Promissory note	(2)		3,921,168		12%
December 10, 2020	December 10, 2023	Promissory note	(3)		3,054,338		12%
December 10, 2020	December 10, 2023	Promissory note	(4)		165,605		12%
December 14, 2020	December 14, 2023	Promissory note	(5)		310,375		12%
December 30, 2020	December 30, 2023	Promissory note	(6)		350,000		12%
January 1, 2021	January 1, 2024	Promissory note	(7)		25,000		12%
January 1, 2021	January 1, 2024	Promissory note	(8)		145,000		12%
January 14, 2021	January 14, 2024	Promissory note	(9)		550,000		12%
February 22, 2021	February 22, 2024	Promissory note	(10)		1,650,000		12%
March 1, 2021	March 1, 2024	Promissory note	(11)		6,000,000		12%
June 8, 2021	June 8, 2024	Promissory note	(12)		2,750,000		12%
July 12, 2021	July 26, 2026	Promissory note	(13)		3,830,360		7%
September 14, 2021	September 14, 2024	Promissory note	(14)		1,650,000		12%
July 28, 2022	July 28, 2023	Promissory note	(15)		—		15%
August 30, 2022	August 30,2024	Promissory note	(16)		3,000,000		15%
September 7, 2022	September 7, 2023	Promissory note	(17)		370,000		15%
September 8, 2022	September 8, 2023	Promissory note	(18)		475,000		15%
October 13, 2022	October 13, 2023	Promissory note	(19)		350,000		15%
October 28, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 9, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 10, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
November 15, 2022	October 31, 2026	Promissory note	(20)		400,000		15%
January 11, 2023	October 31,2026	Promissory note	(20)		400,000		15%
February 6, 2023	October 31, 2026	Promissory note	(20)		400,000		15%
April 5. 2023	October 31, 2026	Promissory note	(20)		400,000		15%
April 20, 23	October 31, 2026	Promissory note	(20)		400,000		15%
May 11, 2023	October 31, 2026	Promissory note	(20)		400,000		15%
				$	32,200,346
Less: current portion of loans payable					(20,369,986	)
Less: discount on non-current loans payable					(4,654,370	)
Non-current loans payable, net of discount				$	7,175,990
Current portion of loans payable				$	20,369,986
Less: discount on current portion of loans payable					(966,767	)
Current portion of loans payable, net of discount				$	19,403,219

* In default

(1)	This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.
(2)	This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(3)	This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(4)	This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.
(5)	This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.
(6)	The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $52,756 and $92,660, respectively, with an unamortized discount of $100,855 at August 31, 2023.
(7)	This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(8)	This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.
(9)	The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $62,143 and $113,188 respectively, with an unamortized discount of $126,148 at August 31, 2023.
(10)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $220,757 and $379,821 respectively, with an unamortized discount of $732,440 at August 31, 2023.

(11)	The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized.
(12)	The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $175,789 and $330,699 respectively, with an unamortized discount of $463,519 at August 31, 2023.
(13)	This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2023 there were repayments of  $27,000 and $54,000 . respectively on the note.
(14)	The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $115,344 and $202,274 respectively, with an unamortized discount of $1,27,501 at August 31, 2023.
(15)	Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $3,739 and $9,026 respectively, with an unamortized discount of $0 at August 31, 2023. This loan has been fully repaid.
(16)	A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $4,736 and $9,293 respectively, with an unamortized discount of $21,576 at August 31, 2023.
(17)	Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000.  Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $15,479 and $27,821 respectively, with an unamortized discount of $0 at August 31, 2023.
(18)	Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $17,799 and $36,729 respectively, with an unamortized discount of $0 at August 31, 2023.
(19)	Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $13,295 and $25,585 respectively, with an unamortized discount of $7,325 at August 31, 2023.

(20) On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At November 30, 2022 the Company has issued 6 tranches as follows:

October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,472 and $4,338 respectively, with an unamortized discount of $343,685 at August 31, 2023.

November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,438 and $4,276 respectively, with an unamortized discount of $344,162 at August 31, 2023.

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,233 and $3,900 respectively, with an unamortized discount of $346,981 at August 31, 2023.

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,489 and $4,370 respectively, with an unamortized discount of $343,445 at August 31, 2023.

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,541 and $4,565 respectively, with an unamortized discount of $342,724 at August 31, 2023.

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,436 and $4,272 respectively, with an unamortized discount of $344,154 at August 31, 2023.

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,523 and $3,274 respectively, with an unamortized discount of $342,971 at August 31, 2023.

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,010 and $2,206 respectively, with an unamortized discount of $350,013 at August 31, 2023.

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $0 and $0 respectively, with an unamortized discount of $398,983 at August 31, 2023.

XML

STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)

6 Months Ended

Aug. 31, 2023

Equity [Abstract]

Summary of Preferred Stock Warrant Activity

Summary of Preferred Stock Warrant Activity

	Number of Series F Preferred Warrants	Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at March 1, 2023	695	$1.00	10.00
Issued	183	1.00	9.88
Exercised	—	—	—
Forfeited and cancelled	—	—	—
Outstanding at August 31, 2023	878	$1.00	9.75

The table below represent the common shares issued, issuable and outstanding at August 31, 2023 and February 28, 2023:

The table below represent the common shares issued, issuable and outstanding at August 31, 2023 and February 28, 2023:

Common shares	August 31, 2023		February 28, 2023
Issued		7,039,806,793		5,836,641,599
Issuable		—		12,100,000
Issued, issuable and outstanding		7,039,806,793		5,848,741,599

Summary of Common Stock Warrant Activity

	Number of Warrants	Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at February 28, 2023	314,217,451	$0.114	1.95
Issued	—	—	—
Exercised	—	—	—
Forfeited and cancelled	—	—	—
Outstanding at August 31, 2023	314,217,451	$0.114	1.45

Summary of Common Stock Option Activity -Employee Stock Options

Summary of Common Stock Option Activity -Employee Stock Options

	Number of Options		Weighted Average Exercise Price	Weighted Average Remaining Years
Outstanding at February 28 , 2023	95,725,000		$0.02	4.75
Issued	—		—	—
Exercised	—		—	—
Forfeited, extinguished and cancelled	(13,025,000	)	$0.02	(4.75)
Outstanding at August 31, 2023	82,700,000		$0.02	4.25

XML

COMMITMENTS AND CONTINGENCIES (Tables)

6 Months Ended

Aug. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis.

Maturity of Lease Liabilities	Operating Leases
August 31, 2024	$	239,669
August 31, 2025		207,558
August 31, 2026		207,558
August 31, 2027		207,558
August 31, 2028		207,558
August 31, 2029 and after		553,488
Total lease payments		1,623,389
Less: Interest		(482,399	)
Present value of lease liabilities	$	1,140,990

XML

EARNINGS (LOSS) PER SHARE (Tables)

6 Months Ended

Aug. 31, 2023

Earnings Per Share [Abstract]

The net income (loss) per common share amounts were determined as follows:

The net income (loss) per common share amounts were determined as follows:

	For the Three Months Ended						For the Six Months Ended
	August 31,						August 31,
	2023			2022			2023			2022
Numerator:
Net income (loss) available to common shareholders	$	(4,759,728	)	$	(4,172,865	)	$	(9,314,919	)	$	(8,844,551	)
Effect of common stock equivalents
Add: interest expense on convertible debt		—			8,543			—			8,737
Add (less) loss (gain) on settlement of debt		—			(3,992	)		—			(3,992	)
Add (less) loss (gain) on change of derivative liabilities		—			(3,595	)		—			(3,595	)
Net income (loss) adjusted for common stock equivalents		(4,759,728	)		(4,171,909	)		(9,314,919	)		(8,843,401	)
Denominator:
Weighted average shares – basic		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362
Net income (loss) per share – basic	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)
Dilutive effect of common stock equivalents:
Convertible Debt		—			—			—			—
Preferred shares		—			—			—			—
Warrants		—			—			—			—
		—			—			—			—
Denominator:
Weighted average shares – diluted		6,568,957,612			4,970,040,852			6,266,833,467			4,884,349,362
Net income (loss) per share – diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.01	)

The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2023 and 2022 were as follows:

The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2023 and 2022 were as follows:

	For the Three Months Ended				For the Six Months Ended
	August 31,				August 31,
	2023		2022		2023		2022
Convertible notes and accrued interest		—		836,425,685		—		836,425,685
Convertible Series F Preferred Shares		24,286,988,436		—		24,286,988,436		—
Stock options and warrants		433,767,451		401,217,451		433,767,451		401,217,451
Total		24,720,755,887		1,237,643,136		24,720,755,887		1,237,643,136

* On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at August 31, 2023 and 2022 the dilutive effects would be as follows:

Series F Preferred shares been convertible the dilutive effects would be as follows:

	For the Three and Six Months Ended
	August 31, 2023	August 31, 2022
Convertible Series F Preferred Shares	—	17,375,422,528

XML

GENERAL INFORMATION (Details Narrative) - shares	Aug. 28, 2017	Aug. 31, 2023	Feb. 28, 2023	Jul. 25, 2017
Restructuring Cost and Reserve [Line Items]
Common stock, issued		7,039,806,793	5,848,741,599
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Common stock, issued				10,000
Robotic Assistance Devices LLC [Member] | Series E Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	3,350,000
Robotic Assistance Devices LLC [Member] | Series F Preferred Stock [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares isuued under acquisition	2,450

XML

GOING CONCERN (Details Narrative) - USD ($)		1 Months Ended	6 Months Ended
	Sep. 26, 2023	Mar. 31, 2023	Aug. 31, 2023
Cash flow from operating activities			$ 6,335,216
Accumulated deficit			121,568,632
Working capital			24,615,965
Additional issuance costs	$ 5,200,000
Minimum [Member]
Other cost cutting management estimates			200,000
Maximum [Member]
Other cost cutting management estimates			$ 300,000
Common Stock [Member]
Purchase of common stock		$ 12,500,000

XML

Fixed assets consisted of the following: (Details)	Aug. 31, 2023
Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years
Computer Equipment and Software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Computer Equipment and Software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Manufacturing Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	7 years
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years
Tooling [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	4 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years

XML

The following table presents information about our liabilities measured at fair value on a recurring basis, aggregated by the level in the fair value hierarchy within which those measurements fell: (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 1,104,000	$ 979,000
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto-Asset [Line Items]
Incentive compensation plan payable revaluation of equity awards payable in Series G shares	$ 1,104,000	$ 979,000

XML

ACCOUNTING POLICIES (Details Narrative)	3 Months Ended		6 Months Ended	12 Months Ended
	Aug. 31, 2023 USD ($) Number	Aug. 31, 2022	Aug. 31, 2023 USD ($) Number	Feb. 28, 2023 USD ($)
Property, Plant and Equipment [Line Items]
Loans payable	$ 32,200,345		$ 32,200,345	$ 31,254,345
Accounts receivable, net	$ 260,671		260,671	265,024	[1]
Percentage of accounts receivable	37.00%	54.00%
Inventory valuation reserves	$ 195,000		$ 195,000	195,000
Depreciation life	48 months		48 months
Deferred development costs	$ 0		$ 0	0
Percentage of revenue	33.00%	26.00%	33.00%
Description of deferred tax assets and liabilities			The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%.
Two Customer [Member]
Property, Plant and Equipment [Line Items]
Number of customers | Number	2		2
Minimum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	2 years		2 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, useful life	5 years		5 years
Controller [Member]
Property, Plant and Equipment [Line Items]
Loans additions			$ 27,890,506	$ 26,540,506
Loans percentage	87.00%		87.00%	85.00%

[1] Derived from audited information

XML

The following table presents revenues from contracts with customers disaggregated by product/service: (Details) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Revenue from Contract with Customer [Abstract]
Device rental activities	$ 343,543	$ 228,214	$ 581,692	$ 468,019
Direct sales of goods and services	42,820	39,270	189,879	184,622
Revenues	$ 386,363	$ 267,484	$ 771,571	$ 652,641

XML

Below is a summary of our lease assets and liabilities at August 31, 2023 and February 28, 2023. (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Leases
Operating lease assets	$ 1,148,682	$ 1,208,440
Current operating lease liability	239,669	248,670	[1]
Noncurrent operating lease liabilities	901,321	950,541	[1]
Total lease liabilities	$ 1,140,990	$ 1,199,211

[1] Derived from audited information

XML

LEASES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Leases
Weighted average remaining lease term	12 months		12 months
Rent	$ 62,541	$ 63,681	$ 125,083	$ 133,648
Operating lease cost	$ 62,541	$ 63,681	$ 125,083	$ 133,648

XML

Revenue earning devices consisted of the following: (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Revenue Earning Devices
Revenue earning devices	$ 2,800,522	$ 2,015,058
Less: Accumulated depreciation	(1,044,294)	(779,839)
Total	$ 1,756,228	$ 1,235,219

XML

REVENUE EARNING DEVICES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Restructuring Cost and Reserve [Line Items]
Revenue earning	$ 386,363	$ 267,484	$ 771,571	$ 652,641
Depreciation expense	191,041	145,793	358,983	239,788
Robotic Assistance Devices LLC [Member]
Restructuring Cost and Reserve [Line Items]
Revenue earning	341,042	251,946	785,464	426,047
Depreciation expense	$ 141,614	$ 116,125	$ 264,455	$ 187,539

XML

Fixed assets consisted of the following: (Details) - USD ($)	Aug. 31, 2023	Feb. 28, 2023
Property, Plant and Equipment [Line Items]
Gross	$ 605,121	$ 497,890
Less: accumulated depreciation	(276,530)	(182,002)
Fixed assets, net of accumulated depreciation	328,591	315,888	[1]
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Gross	101,680	101,680
Demo Devices [Member]
Property, Plant and Equipment [Line Items]
Gross	172,778	69,010
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Gross	101,322	101,322
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross	8,825	8,825
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross	150,387	150,387
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross	15,312	15,312
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Gross	21,225	21,225
Warehouse Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross	14,561	14,561
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross	$ 19,031	$ 15,568

[1] Derived from audited information

XML

FIXED ASSETS (Details Narrative) - Robotic Assistance Devices LLC [Member] - USD ($)	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Restructuring Cost and Reserve [Line Items]
Additions to fixed assets	$ 75,057	$ 139,946	$ 107,230	$ 233,676
Assets transfers from inventory		20,693	103,767	26,479
Remaining additions to fixed assets		118,983	3,463	207,197
Depreciation expense	$ 49,427	$ 29,668	$ 94,528	$ 52,249

XML

DEFERRED VARIABLE PAYMENT OBLIGATION (Details Narrative) - USD ($)										3 Months Ended	6 Months Ended		12 Months Ended
	Mar. 03, 2021	Aug. 27, 2020	Jul. 01, 2020	Apr. 22, 2020	Feb. 29, 2020	Dec. 30, 2019	Nov. 18, 2019	May 09, 2019	Feb. 01, 2019	May 31, 2021	Aug. 31, 2023	Aug. 27, 2021	Feb. 28, 2023
Principal amount											$ 32,200,346
Accrued payment											667,634		$ 542,177
Default on payments											431,719		325,600
Aggregate investment	$ 1,925,000
Total payment obligation											2,525,000		2,525,000	[1]
Payment receive											$ 0		0
Investor [Member]
Maximum amount of debt		$ 1,925,000	$ 800,000	$ 100,000					$ 900,000
Percentage of exchange rate		14.25%	2.75%	1.00%		1.00%			9.00%
Debt instrument, date of first required payment					Feb. 29, 2020
Description of variable payments terms											These variable payments (Payments) are to be made 30 days after the end of each fiscal quarter. If the Payments would deplete RAD’s available cash by more than 30%, the Payments may be deferred for up to 12 months after the quarterly report at an interest rate of 6% per annum on the unpaid amount.
Description of disposition price											The FMV cannot exceed 30% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments.	The FMV cannot exceed 43.77% of the share disposition price defined as the total price the third party paid for the shares plus the total value of all future Payments. As of March 1, 2021 as a result of the amendment with the first investor noted below. This aggregate asset disposition % was reduced from 43.77 % to 33.77%.
Principal amount					$ 109,000		$ 225,000
Advance amount					116,000
Investor [Member] | Series F Preferred Stock [Member]
Purchase of warrant	367									38
Exercise price	$ 1.00
Fair value of warrants										$ 33,015,214
Investor [Member] | Maximum [Member]
Percentage of exchange rate	14.25%
Percentage of total asset disposition price	31.00%
Investor [Member] | Minimum [Member]
Percentage of exchange rate	9.65%
Percentage of total asset disposition price	21.00%
Investor [Member] | Agreement [Member]
Maximum amount of debt		$ 900,000
Investor [Member] | Agreement One [Member]
Maximum amount of debt		225,000
Investor [Member] | Ageement Two [Member]
Maximum amount of debt		$ 800,000
Investor One [Member]
Maximum amount of debt					400,000			$ 400,000
Percentage of exchange rate								4.00%
Investor Two [Member]
Maximum amount of debt					$ 50,000			$ 50,000
Percentage of exchange rate								1.11%
Investor Four [Member]
Percentage of exchange rate							2.25%
Investor Five [Member]
Description of variable payments terms			If the Payments would deplete RAD’s available cash by more than 20%, the payment may be deferred. The investor had agreed to pay $100,000 per month over an 8 month period with the first payment due July 2020 and the final payment no later than February 28, 2021. As at August 31, 2020 the investor had fully funded the $800,000 commitment.
Investor Eight [Member]
Percentage of assets sold		10.00%
Investor Eight [Member]
Total payment obligation											$ 2,525,000		2,525,000
Deferred payment obligation											$ 2,525,000		$ 2,525,000

[1] Derived from audited information

XML

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023	Feb. 28, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Net borrowings on loan payable - related party			$ 0	$ 0
Loan payable - related party	$ 260,746		260,746		$ 206,516
Balance due to related party	172,265		172,265		$ 108,000
Interest Expense	1,753,216	$ 1,002,020	$ 3,359,432	2,177,050
Percentage of interest expense due to related party			12.00%		12.00%
Deferred salary payable to related party					$ 108,000
Interest accrued related party			$ 23,515			$ 15,660
Consulting fees for research and development	$ 777,260	$ 957,395	$ 1,659,275	$ 1,959,129
Incentives Compensation Plan [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Share price	$ 1,000		$ 1,000

XML

OTHER DEBT – VEHICLE LOAN (Details Narrative) - USD ($)	1 Months Ended		6 Months Ended
	Nov. 30, 2017	Dec. 31, 2016	Aug. 31, 2023	Feb. 28, 2023	Feb. 28, 2022	Feb. 28, 2021	Feb. 28, 2020	Feb. 28, 2019
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile			$ 32,200,346
Principal repayments of loan					$ 0	$ 0
Proceeds of disposal of vehicle offset against vehicle loan			18,766
Remaining asset value			5,515
Reclassification of fixed assets to vehicle for disposal			13,251
Robotic Assistance Devices LLC [Member] | Secured Debt [Member]
Restructuring Cost and Reserve [Line Items]
Vehicle loan secured by automobile	$ 47,661	$ 47,704
Term of debt	5 years	5 years
Maturity date	Oct. 24, 2022	Nov. 09, 2021
Payment of debt interest and principal	$ 923	$ 1,019
Outstanding balance of the loan								$ 21,907
Loss on sale of vehicle			3,257
Current portion vehicle loan						21,578	$ 21,578
Long-term vehicle loan					$ 16,944	$ 16,944
Total vehicle loan			$ 38,522	$ 38,522

XML

Loans payable at August 31, 2023 consisted of the following: (Details) - USD ($)												3 Months Ended			6 Months Ended			12 Months Ended
		May 11, 2023	Apr. 20, 2023	Apr. 05, 2023	Feb. 06, 2023	Jan. 11, 2023	Nov. 15, 2022	Nov. 10, 2022	Nov. 09, 2022	Oct. 28, 2022	Feb. 28, 2022	Aug. 31, 2023		Aug. 31, 2022	Aug. 31, 2023		Aug. 31, 2022	Feb. 28, 2023	Feb. 28, 2021
Short-Term Debt [Line Items]
Debt instrument, face amount												$ 32,200,346			$ 32,200,346
Less: current portion of loans payable												(20,369,986)			(20,369,986)
Less: discount on non-current loans payable												(4,654,370)			(4,654,370)
Non-current loans payable, net of discount												7,175,990			7,175,990
Current portion of loans payable												20,369,986			20,369,986
Less: discount on current portion of loans payable												(966,767)			(966,767)
Current portion of loans payable, net of discount												$ 19,403,219			$ 19,403,219
Warrant purchase												6,500,000			6,500,000			12,100,000
Fair value of warrants											$ 0								$ 0
Interest expenses												$ 1,753,216		$ 1,002,020	$ 3,359,432		$ 2,177,050
Promissory Note Payable 01 [Member]
Short-Term Debt [Line Items]
Date of issuance	[1],[2]														Jul. 18, 2016
Debt instrument, face amount	[1],[2]											$ 3,500			$ 3,500
Annual interest rate	[1],[2]											22.00%			22.00%
Promissory Note Payable 02 [Member]
Short-Term Debt [Line Items]
Date of issuance	[3]														Dec. 10, 2020
Debt instrument, face amount	[3]											$ 3,921,168			$ 3,921,168
Annual interest rate	[3]											12.00%			12.00%
Debt settlement amount												$ 2,683,357			$ 2,683,357
Accrued interest												$ 1,237,811			1,237,811
Promissory Note Payable 02 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion															$ 3,921,168
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.002			$ 0.002
Fair value of notes															$ 990,000
Promissory Note Payable 03 [Member]
Short-Term Debt [Line Items]
Date of issuance	[4]														Dec. 10, 2020
Debt instrument, face amount	[4]											$ 3,054,338			$ 3,054,338
Annual interest rate	[4]											12.00%			12.00%
Debt settlement amount												$ 1,460,794			$ 1,460,794
Accrued interest												$ 1,593,544			1,593,544
Promissory Note Payable 03 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion															$ 3,054,338
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.002			$ 0.002
Fair value of notes															$ 550,000
Promissory Note Payable04 [Member]
Short-Term Debt [Line Items]
Date of issuance	[5]														Dec. 10, 2020
Debt instrument, face amount	[5]											$ 165,605			$ 165,605
Annual interest rate	[5]											12.00%			12.00%
Debt settlement amount												$ 103,180			$ 103,180
Accrued interest												$ 62,425			62,425
Promissory Note Payable04 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion															$ 165,605
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.002			$ 0.002
Fair value of notes															$ 176,000
Warrant purchase															80,000,000
Promissory Note Payable05 [Member]
Short-Term Debt [Line Items]
Date of issuance	[6]														Dec. 14, 2020
Debt instrument, face amount	[6]											$ 310,375			$ 310,375
Annual interest rate	[6]											12.00%			12.00%
Debt settlement amount												$ 235,000			$ 235,000
Accrued interest												$ 75,375			75,375
Promissory Note Payable05 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion															$ 310,375
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.002			$ 0.002
Fair value of notes															$ 182,500
Warrant purchase															25,000,000
Promissory Note Payable 06 [Member]
Short-Term Debt [Line Items]
Date of issuance	[7]														Dec. 30, 2020
Debt instrument, face amount	[7]											$ 350,000			$ 350,000
Annual interest rate	[7]											12.00%			12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.025			$ 0.025
Original issue discount															$ 35,000
Warrants issued															50,000,000
Class of warrant or right warrants term															3 years
Fair value of warrants												$ 271,250			$ 271,250
Debt discount												271,250			271,250
Amortization expens												52,756			92,660
Debt instrument, unamortized discount												100,855			$ 100,855
Promissory Note Payable 07 [Member]
Short-Term Debt [Line Items]
Date of issuance	[8]														Jan. 01, 2021
Debt instrument, face amount	[8]											$ 25,000			$ 25,000
Annual interest rate	[8]											12.00%			12.00%
Debt settlement amount												$ 9,200			$ 9,200
Accrued interest												6,944			6,944
Promissory Note Payable 07 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Common stock issued for debt conversion															$ 16,144
Promissory Note Payable 08 [Member]
Short-Term Debt [Line Items]
Date of issuance	[9]														Jan. 01, 2021
Debt instrument, face amount	[9]											$ 145,000			$ 145,000
Annual interest rate	[9]											12.00%			12.00%
Debt settlement amount												$ 79,500			$ 79,500
Accrued interest												28,925			28,925
Promissory Note Payable 08 [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount												145,000			145,000
Common stock issued for debt conversion															$ 108,425
Promissory Note Payable 09 [Member]
Short-Term Debt [Line Items]
Date of issuance	[10]														Jan. 14, 2021
Debt instrument, face amount	[10]											$ 550,000			$ 550,000
Annual interest rate	[10]											12.00%			12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.025			$ 0.025
Original issue discount															$ 250,000
Warrants issued															50,000,000
Class of warrant or right warrants term															3 years
Fair value of warrants												$ 380,174			$ 380,174
Debt discount												380,174			380,174
Amortization expens												62,143			113,188
Debt instrument, unamortized discount												126,148			$ 126,148
Promissory Note Payable10 [Member]
Short-Term Debt [Line Items]
Date of issuance	[11]														Feb. 22, 2021
Debt instrument, face amount	[11]											$ 1,650,000			$ 1,650,000
Annual interest rate	[11]											12.00%			12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 0.0164	$ 0.135			$ 0.135
Original issue discount															$ 150,000
Warrants issued															100,000,000
Class of warrant or right warrants term															3 years
Fair value of warrants												$ 1,342,857			$ 1,342,857
Debt discount												1,342,857			1,342,857
Amortization expens												220,757			379,821
Debt instrument, unamortized discount												732,440			$ 732,440
Interest expenses											$ 950,000
Promissory Note Payable10 [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Warrants issued															50,000,000
Class of warrant or right warrants term											3 years
Promissory Note Payable11 [Member]
Short-Term Debt [Line Items]
Date of issuance	[12]														Mar. 01, 2021
Debt instrument, face amount	[12]											$ 6,000,000			$ 6,000,000
Annual interest rate	[12]											12.00%			12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.135			$ 0.135
Warrants issued															300,000,000
Class of warrant or right warrants term															3 years
Debt discount												$ 4,749,005			$ 4,749,005
Interest expenses											$ 2,850,000
Proceeds from issuance of debt															5,400,000
Debt conversion original debt amount 1															600,000
Promissory Note Payable11 [Member] | Valuation Technique, Option Pricing Model [Member]
Short-Term Debt [Line Items]
Fair value of warrants															$ 4,749,005
Promissory Note Payable11 [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 0.0164
Warrants issued															150,000,000
Class of warrant or right warrants term											3 years
Promissory Note Payable12 [Member]
Short-Term Debt [Line Items]
Date of issuance	[13]														Jun. 08, 2021
Debt instrument, face amount	[13]											$ 2,750,000			$ 2,750,000
Annual interest rate	[13]											12.00%			12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.064			$ 0.064
Original issue discount															$ 50,000
Warrants issued															170,000,000
Class of warrant or right warrants term															3 years
Fair value of warrants												$ 2,035,033			$ 2,035,033
Debt discount												2,035,033			2,035,033
Amortization expens												175,789			330,699
Debt instrument, unamortized discount												463,519			$ 463,519
Interest expenses											$ 1,615,000
Promissory Note Payable12 [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 0.0164
Warrants issued															85,000,000
Class of warrant or right warrants term											3 years
Promissory Note Payable13 [Member]
Short-Term Debt [Line Items]
Date of issuance	[14]														Jul. 12, 2021
Debt instrument, face amount	[14]											$ 3,830,360			$ 3,830,360
Annual interest rate	[14]											7.00%			7.00%
Principal ammount												$ 4,000,160			$ 4,000,160
Repayment of notes												27,000			$ 54,000
Promissory Note Payable14 [Member]
Short-Term Debt [Line Items]
Date of issuance	[15]														Sep. 14, 2021
Debt instrument, face amount	[15]											$ 1,650,000			$ 1,650,000
Annual interest rate	[15]											12.00%			12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.037			$ 0.037
Original issue discount															$ 150,000
Warrants issued															250,000,000
Class of warrant or right warrants term															3 years
Fair value of warrants												$ 1,284,783			$ 1,284,783
Debt discount												1,284,783			1,284,783
Amortization expens												115,344			202,274
Debt instrument, unamortized discount												127,501			$ 127,501
Promissory Note Payable15 [Member]
Short-Term Debt [Line Items]
Date of issuance	[16]														Jul. 28, 2022
Debt instrument, face amount												$ 170,000			$ 170,000
Annual interest rate	[16]											15.00%			15.00%
Original issue discount															$ 20,000
Amortization expens												$ 3,739			9,026
Debt instrument, unamortized discount												0			$ 0
Promissory Note Payable16 [Member]
Short-Term Debt [Line Items]
Date of issuance	[17]														Aug. 30, 2022
Debt instrument, face amount	[17]											$ 3,000,000			$ 3,000,000
Annual interest rate	[17]											15.00%			15.00%
Debt discount												$ 39,500			$ 39,500
Amortization expens												4,736			9,293
Debt instrument, unamortized discount												$ 21,576			$ 21,576
Class of warrant or right outstanding												955,000,000			955,000,000
Rate of interest												15.00%			15.00%
Class of warrant or right, outstanding															$ 2,960,500
Promissory Note Payable17 [Member]
Short-Term Debt [Line Items]
Date of issuance	[18]														Sep. 07, 2022
Debt instrument, face amount	[18]											$ 370,000			$ 370,000
Annual interest rate	[18]											15.00%			15.00%
Original issue discount															$ 50,000
Amortization expens												$ 15,479			27,821
Debt instrument, unamortized discount												0			$ 0
Promissory Note Payable18 [Member]
Short-Term Debt [Line Items]
Date of issuance	[19]														Sep. 08, 2022
Debt instrument, face amount	[19]											$ 475,000			$ 475,000
Annual interest rate	[19]											15.00%			15.00%
Original issue discount															$ 75,000
Amortization expens												$ 17,799			36,729
Debt instrument, unamortized discount												0			$ 0
Promissory Note Payable19 [Member]
Short-Term Debt [Line Items]
Date of issuance	[20]														Oct. 13, 2022
Debt instrument, face amount	[20]											$ 350,000			$ 350,000
Annual interest rate	[20]											15.00%			15.00%
Original issue discount															$ 50,000
Amortization expens												$ 13,295			25,585
Debt instrument, unamortized discount												7,325			$ 7,325
Promissory Note Payable20 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Oct. 28, 2022
Debt instrument, face amount	[21]											$ 400,000			$ 400,000
Annual interest rate	[21]											15.00%			15.00%
Line of credit facility												$ 4,000,000			$ 4,000,000
Promissory Note Payable 21 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Nov. 09, 2022
Debt instrument, face amount										$ 400,000		$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount										$ 50,000
Amortization expens												$ 2,472			$ 4,338
Debt instrument, unamortized discount												343,685			$ 343,685
Promissory Note Payable 22 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Nov. 10, 2022
Debt instrument, face amount									$ 400,000			$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount									$ 50,000
Amortization expens												$ 2,438			$ 4,276
Debt instrument, unamortized discount												344,162			$ 344,162
Promissory Note Payable 23 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Nov. 15, 2022
Debt instrument, face amount								$ 400,000				$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount								$ 50,000
Amortization expens												$ 2,233			$ 3,900
Debt instrument, unamortized discount												346,981			$ 346,981
Promissory Note Payable 24 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Jan. 11, 2023
Debt instrument, face amount							$ 400,000					$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount							$ 50,000
Amortization expens												$ 2,489			$ 4,370
Debt instrument, unamortized discount												343,445			$ 343,445
Promissory Note Payable 25 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Feb. 06, 2023
Debt instrument, face amount						$ 400,000						$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount						$ 50,000
Amortization expens												$ 2,541			$ 4,565
Debt instrument, unamortized discount												342,724			$ 342,724
Promissory Note Payable 26 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Apr. 05, 2023
Debt instrument, face amount					$ 400,000							$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount					$ 50,000
Amortization expens												$ 2,436			$ 4,272
Debt instrument, unamortized discount												344,154			$ 344,154
Promissory Note Payable 27 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														Apr. 20, 2023
Debt instrument, face amount				$ 400,000								$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount				$ 50,000
Amortization expens												$ 2,523			$ 3,274
Debt instrument, unamortized discount												342,971			$ 342,971
Promissory Note Payable 28 [Member]
Short-Term Debt [Line Items]
Date of issuance	[21]														May 11, 2023
Debt instrument, face amount			$ 400,000									$ 400,000	[21]		$ 400,000	[21]
Annual interest rate	[21]											15.00%			15.00%
Original issue discount			$ 50,000
Amortization expens												$ 2,010			$ 2,206
Debt instrument, unamortized discount												350,013			350,013
Promissory Note Payable 29 [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount		$ 400,000
Original issue discount		$ 50,000
Amortization expens												0			0
Debt instrument, unamortized discount												$ 398,983			$ 398,983

[1] In default

[2] This note was transferred from convertible notes payable because in August 2022 it was no longer convertible due to restrictions placed on the lender.

[3] This promissory note was issued as part of a debt settlement whereby $2,683,357 in convertible notes and associated accrued interest of $1,237,811 totaling $3,921,168 was exchanged for this promissory note of $3,921,168, and a warrant to purchase 450,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $990,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.

[4] This promissory note was issued as part of a debt settlement whereby $1,460,794 in convertible notes and associated accrued interest of $1,593,544 totaling $3,054,338 was exchanged for this promissory note of $3,054,338, and a warrant to purchase 250,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a relative fair value of $550,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.

[5] This promissory note was issued as part of a debt settlement whereby $103,180 in convertible notes and associated accrued interest of $62,425 totaling $165,605 was exchanged for this promissory note of $165,605, and a warrant to purchase 80,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $176,000.

[6] This promissory note was issued as part of a debt settlement whereby $235,000 in convertible notes and associated accrued interest of $75,375 totaling $310,375 was exchanged for this promissory note of $310,375, and a warrant to purchase 25,000,000 shares at an exercise price of $.002 per share and a three-year maturity having a fair value of $182,500.

[7] The note, with an original principal amount of $350,000, may be pre-payable at any time. The note balance includes an original issue discount of $35,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $271,250. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $271,250 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $52,756 and $92,660, respectively, with an unamortized discount of $100,855 at August 31, 2023.

[8] This promissory note was issued as part of a debt settlement whereby $9,200 in convertible notes and associated accrued interest of $6,944 totaling $16,144 was exchanged for this promissory note of $25,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.

[9] This promissory note was issued as part of a debt settlement whereby $79,500 in convertible notes and associated accrued interest of $28,925 totaling $108,425 was exchanged for this promissory note of $145,000. This note is secured by a general security charging all of the Company’s present and after-acquired property.

[10] The note, with an original principal amount of $550,000, may be pre-payable at any time. The note balance includes an original issue discount of $250,000 and was issued with a warrant to purchase 50,000,000 shares at an exercise price of $0.025 per share with a 3-year term and having a relative fair value of $380,174. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $380,174 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $62,143 and $113,188 respectively, with an unamortized discount of $126,148 at August 31, 2023.

[11] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 100,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $1,342,857. The discount and warrant are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,342,857 with a corresponding adjustment to paid in capital for the relative fair value of the warrant. The maturity date was extended from February 22, 2022 to February 22, 2024 on February 28, 2022 in exchange for warrants to purchase 50,000,000 at an exercise price of $.0164 and a 3-year term. These warrants have a fair value of $950,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $220,757 and $379,821 respectively, with an unamortized discount of $732,440 at August 31, 2023.

[12] The unsecured note may be pre-payable at any time. Cash proceeds of $5,400,000 were received. The note balance of $6,000,000 includes an original issue discount of $600,000 and was issued with a warrant to purchase 300,000,000 shares at an exercise price of $0.135 per share with a 3-year term and having a relative fair value of $4,749,005 using Black-Scholes with assumptions described in note 13. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $4,749,005 with a corresponding adjustment to paid in capital for the relative value of the warrant.. The maturity was extended from March 1, 2022 to March 1, 2024 on February 28, 2022 in exchange for warrants to purchase 150,000,000 shares of common stock at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $2,850,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. This note has been fully amortized.

[13] The note, with an original principal balance of $2,750,000, may be pre-payable at any time. The note balance includes an original issue discount of $50,000 and was issued with a warrant to purchase 170,000,000 shares at an exercise price of $0.064 per share with a 3-year term and having a relative fair value of $2,035,033. The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $2,035,033 with a corresponding adjustment to paid in capital. The maturity date was extended from June 8, 2022 to June 8, 2024 on February 28, 2022 in exchange for warrants to purchase 85,000,000 at an exercise price of $.0164 and a 3 year term. These warrants have a fair value of $1,615,000 recorded as interest expense with a corresponding adjustment to paid in capital recorded in the year ended February 28, 2022. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $175,789 and $330,699 respectively, with an unamortized discount of $463,519 at August 31, 2023.

[14] This loan, with an original principal balance of $4,000,160, was in exchange for 184 Series F preferred shares from a former director. The interest and principal are payable at maturity. The loan is unsecured. For the three and six months ended August 31, 2023 there were repayments of  $27,000 and $54,000 . respectively on the note.

[15] The note, with an original principal balance of $1,650,000, may be pre-payable at any time. The note balance includes an original issue discount of $150,000 and was issued with a warrant to purchase 250,000,000 shares at an exercise price of $0.037 per share with a 3-year term and having a relative fair value of $1,284,783, The discounts are being amortized over the term of the loan. After allocating these charges to debt and equity according to their respective values, a debt discount of $1,284,783 with a corresponding adjustment to paid in capital. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $115,344 and $202,274 respectively, with an unamortized discount of $1,27,501 at August 31, 2023.

[16] Original $170,000 note may be pre-payable at any time. The note balance includes an original issue discount of $20,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $3,739 and $9,026 respectively, with an unamortized discount of $0 at August 31, 2023. This loan has been fully repaid.

[17] A warrant holder exchanged 955,000,000 warrants for a promissory note of $3,000,000, bearing interest at 15% with a two year maturity. The fair value of the warrants was determined to be $2,960,500 with a corresponding adjustment to paid-in capital and a debt discount of $39,500 which will be amortized over the term of the loan. Principal and interest due at maturity. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $4,736 and $9,293 respectively, with an unamortized discount of $21,576 at August 31, 2023.

[18] Original $400,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000.  Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $15,479 and $27,821 respectively, with an unamortized discount of $0 at August 31, 2023.

[19] Original $475,000 note may be pre-payable at any time. The note balance includes an original issue discount of $75,000. Principal and interest due at maturity. Secured by a general security charging all of RAD’s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $17,799 and $36,729 respectively, with an unamortized discount of $0 at August 31, 2023.

[20] Original $350,000 note may be pre-payable at any time. The note balance includes an original issue discount of $50,000. Principal and interest due at maturity. Secured by a general security charging all of the Company’s s present and after-acquired property. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $13,295 and $25,585 respectively, with an unamortized discount of $7,325 at August 31, 2023.

[21] On October 28, 2022 the Company entered into an loan facility with a lender for up to $4,000,000 including an original issue discount of $500,000. In exchange the Company will issue one series F Preferred Share, extended 329 series F warrants with a March 1, 2026 maturity to a new October 31, 2033 maturity, and issue up to 10 tranches with each tranche of $400,000, with cash proceeds of $350,000 an original issue discount of $50,000, October 31, 2026 maturity, and 61 Series F warrants with a October 31, 2033 maturity. Secured by a general security charging all of the Company’s present and after-acquired property. At November 30, 2022 the Company has issued 6 tranches as follows:

October 28, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants and 1 Series F Preferred Share having a relative fair value of $299,399. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,472 and $4,338 respectively, with an unamortized discount of $343,685 at August 31, 2023.

November 9, 2022, $400,000 loan, original issue discount of $50,000 , 61 Series F Preferred Share warrants having a relative fair value of $299,750. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,438 and $4,276 respectively, with an unamortized discount of $344,162 at August 31, 2023.

November 10, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,020. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,233 and $3,900 respectively, with an unamortized discount of $346,981 at August 31, 2023.

November 15, 2022, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,489 and $4,370 respectively, with an unamortized discount of $343,445 at August 31, 2023.

January 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,541 and $4,565 respectively, with an unamortized discount of $342,724 at August 31, 2023.

February 6, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $299,959. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,436 and $4,272 respectively, with an unamortized discount of $344,154 at August 31, 2023.

April 5, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $296,245. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,523 and $3,274 respectively, with an unamortized discount of $342,971 at August 31, 2023.

April 20, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $302,219. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $2,010 and $2,206 respectively, with an unamortized discount of $350,013 at August 31, 2023.

May 11, 2023, $400,000 loan, original issue discount of $50,000, 61 Series F Preferred Share warrants having a relative fair value of $348,983. For the three and six months ended August 31, 2023, the Company recorded amortization expense of $0 and $0 respectively, with an unamortized discount of $398,983 at August 31, 2023.

XML

Summary of Preferred Stock Warrant Activity (Details) - Preferred Stock [Member] - Warrant [Member]	6 Months Ended
	Aug. 31, 2023 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning | shares	695
Weighted average exercise price at beginning | $ / shares	$ 1.00
Weighted average remaining years beginning	10 years
Issued | shares	183
Issued | $ / shares	$ 1.00
Issued	9 years 10 months 17 days
Exercised | shares	0
Exercised | $ / shares
Forfeited and cancelled | shares	0
Forfeited and cancelled | $ / shares
Outstanding at ending | shares	878
Weighted average exercise price at ending | $ / shares	$ 1.00
Weighted average remaining years ending	9 years 9 months

XML

The table below represent the common shares issued, issuable and outstanding at August 31, 2023 and February 28, 2023: (Details) - shares	Aug. 31, 2023	Feb. 28, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	7,039,806,793	5,848,741,599
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issued	7,039,806,793	5,836,641,599
Issuable		12,100,000
Issued, issuable and outstanding	7,039,806,793	5,848,741,599

XML

Summary of Common Stock Warrant Activity (Details) - Common Stock [Member] - Warrant [Member]	6 Months Ended
	Aug. 31, 2023 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Outstanding at beginning | shares	314,217,451
Weighted average exercise price at beginning | $ / shares	$ 0.114
Outstanding at beginning (in years)	1 year 11 months 12 days
Issued | shares
Issued | $ / shares
Exercised | shares
Exercised | $ / shares
Forfeited and cancelled | shares
Forfeited and cancelled | $ / shares
Outstanding at ending | shares	314,217,451
Weighted average exercise price at ending | $ / shares	$ 0.114
Outstanding at ending (in years)	1 year 5 months 12 days

XML

Summary of Common Stock Option Activity -Employee Stock Options (Details) - Equity Option [Member] - $ / shares	6 Months Ended
	Aug. 31, 2023	Feb. 28, 2023
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Outstanding at beginning	95,725,000
Outstanding at beginning	$ 0.02
Weighted average remaining years	4 years 2 months 30 days	4 years 9 months
Issued
Issued
Exercised
Exercised
Forfeited, extinguished and cancelled	(13,025,000)
Forfeited, extinguished and cancelled	$ 0.02
Weighted average remaining years	4 years 9 months
Outstanding at ending	82,700,000
Outstanding at ending	$ 0.02

XML

STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Increase in shares authorization	10,000,000,000		10,000,000,000		10,000,000,000
Issuance of shares	6,500,000		6,500,000		12,100,000
Fair value	$ 44,460		$ 44,460
Payment for services	83,200		$ 83,200
Gain on settlement of debt	$ 38,640
Equity Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of shares	903,636,004		1,184,565,194
Gross proceeds	$ 4,972,795		$ 6,372,989
Issuance costs	4,796,193		6,115,032
Net proceeds	$ 176,672		$ 257,956
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Increase in shares authorization	7,225,000,000		7,225,000,000
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Increase in shares authorization	10,000,000,000		10,000,000,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Relative fair value	$ 947,447		$ 947,447
Share based compensation	$ 50,713	$ 103,434	$ 0	$ 0

XML

Summary of rent expense and operating lease cost are recorded over the lease terms on a straight-line basis. (Details)	Aug. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
August 31, 2024	$ 239,669
August 31, 2025	207,558
August 31, 2026	207,558
August 31, 2027	207,558
August 31, 2028	207,558
August 31, 2029 and after	553,488
Total lease payments	1,623,389
Less: Interest	(482,399)
Present value of lease liabilities	$ 1,140,990

XML

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)					3 Months Ended		6 Months Ended
	Jan. 28, 2022	Sep. 30, 2021	Mar. 10, 2021	Dec. 18, 2020	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022	Feb. 28, 2023	[1]
Commitments and Contingencies Disclosure [Abstract]
Entity address							the Company entered into a 15-month lease agreement for office space at 18009 Sky Park Circle Suite E, Irvine CA, 92614, commencing on December 18, 2020 through to March 31, 2022 with a minimum base rent of $3,859 per month.
Annual rent	$ 1,500	$ 1,538	$ 15,880	$ 3,859
Security deposit	$ 1,500	$ 18,462	$ 15,880	$ 3,859	$ 21,239		$ 21,239		$ 21,239
Entity address							the Company entered into a 10 year lease agreement for q manufacturing facility at 10800 Galaxie Avenue, Ferndale, Michigan, 48220, commencing on May 1, 2021 through to April 30, 2031 with a minimum base rent of $15,880 per month.
Entity address							the Company entered into a 3-year lease agreement for a vehicle commencing September 30, 2021 through to April 30, 2031 with a minimum base rent of $1,538 per month.
Entity address							the Company entered into a 2-year lease agreement for office space at 1516 E Edinger, Santa Ana, California, 92705, commencing on February 1, 2022 through to January 31, 2024 with a minimum base rent of $1,500 per month.
Rent expense and operating lease cost					$ 62,541	$ 63,681	$ 125,083	$ 133,648

[1] Derived from audited information

XML

The net income (loss) per common share amounts were determined as follows: (Details) - USD ($)	3 Months Ended				6 Months Ended
	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Earnings Per Share [Abstract]
Net Income (Loss) Attributable to Parent	$ (4,759,728)	$ (4,555,193)	$ (4,172,865)	$ (4,671,686)	$ (9,314,919)	$ (8,844,551)
Interest on Convertible Debt, Net of Tax			8,543			8,737
Realized Gain (Loss), Derivative and Foreign Currency Transaction Price Change, Operating, before Tax			(3,595)			(3,595)
Net Income (Loss) Available to Common Stockholders, Diluted	$ (4,759,728)		$ (4,171,909)		$ (9,314,919)	$ (8,843,401)
Weighted Average Number of Shares Outstanding Basic1	6,568,957,612		4,970,040,852		6,266,833,467	4,884,349,362
Weighted Average Number of Shares Outstanding, Diluted, Adjustment	6,568,957,612		4,970,040,852		6,266,833,467	4,884,349,362

XML

The anti-dilutive shares of common stock equivalents for the three and six months ended August 31, 2023 and 2022 were as follows: (Details) - shares		3 Months Ended		6 Months Ended
		Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		24,720,755,887	1,237,643,136	24,720,755,887	1,237,643,136
Series F Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	[1]	24,286,988,436		24,286,988,436
Stock Options and Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		433,767,451	401,217,451	433,767,451	401,217,451
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			836,425,685		836,425,685

[1] On August 23, 2021, the Company filed amended Series F preferred shares such that Series F preferred shares are not convertible into common stock by a holder until (A) August 23, 2023 or (B) the date on which such a conversion may be required for the purpose of (i) uplisting the Company to a new stock exchange, or (ii) selling more than 50% of the Company’s assets. Had these Series F preferred shares been convertible at August 31, 2023 and 2022 the dilutive effects would be as follows:

XML

Series F Preferred shares been convertible the dilutive effects would be as follows: (Details) - shares	3 Months Ended		6 Months Ended
	Aug. 31, 2023	Aug. 31, 2022	Aug. 31, 2023	Aug. 31, 2022
Earnings Per Share [Abstract]
Convertible series F preferred shares	0	17,375,422,528	0	17,375,422,528

XML

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Share Purchase Agreement [Member]	Oct. 12, 2023 USD ($) shares
Subsequent Event [Line Items]
Issuance of shares | shares	120,905,263
Gross proceeds	$ 377,224
Issuance costs	8,569
Net proceeds	$ 368,655